hg_100440.1

Basic information about the TSS

---

TSS ID: hg_100440.1 Species: human Chr: chr9		Start: 33167151 End: 33167172 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: NM_001378495 KJ901453 X55415 AB590749 Distance: 0 GeneID: 2683 HGNC/MGI_ID: HGNC:924 UniProt_ID:

Gene_name: beta-1,4-galactosyltransferase 1 Gene_symbol: B4GALT1 Gene_synonyms: beta4Gal-T1 Gene_source: HGNC:924

TATA-Box annotation

---

Distance to TSS:	196
Nearest PromoterID:	NM_001497
Entrez ID:	2683
Nearest Unigene:	Hs.272011
Nearest Refseq:	NM_001497
Nearest Ensembl:	ENSG00000086062
Gene Name:	beta-1,4-galactosyltransferase 1
Gene Alias:	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1
Gene Description:	beta-1,4-galactosyltransferase 1
Gene Type:	protein-coding
CpG%:	0.13
GC%:	0.746269
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	-30(CTTCTTAAAGCG,+,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@B4GALT1 p2@B4GALT1 p3@B4GALT1 p4@B4GALT1 p5@B4GALT1 p6@B4GALT1 p7@B4GALT1 p9@B4GALT1 p10@B4GALT1
Sample		p1@B4GALT1	p2@B4GALT1	p3@B4GALT1	p4@B4GALT1	p5@B4GALT1	p6@B4GALT1	p7@B4GALT1	p9@B4GALT1	p10@B4GALT1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	5.06	3.31	4.09	3.12	0.97	0.58	0.19	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	5.66	4.45	5.06	3.03	0.81	0.81	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	4.44	3.67	5.21	3.86	0.77	0.39	0.00	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.16	2.49	6.24	4.78	0.21	0.83	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	6.07	3.60	5.85	4.50	0.90	0.90	0.22	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	4.26	2.33	5.43	5.23	0.39	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	5.45	5.01	6.10	3.92	0.44	1.31	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	4.60	4.36	5.33	3.15	0.73	0.97	0.24	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	3.85	6.20	3.85	2.78	0.00	0.43	0.00	0.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.06	6.96	4.06	5.22	1.74	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	2.43	5.26	6.47	2.43	0.40	0.40	0.00	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	2.85	5.69	3.66	2.85	0.41	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	63.99	46.91	16.93	21.92	2.90	1.29	5.00	0.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	44.65	32.48	13.38	17.29	1.05	1.50	3.46	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	68.06	39.74	13.83	17.13	1.98	1.10	3.51	1.32	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	69.66	41.24	14.08	26.41	1.51	1.26	3.27	3.27	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	58.10	30.36	13.76	26.65	1.53	1.09	1.97	0.87	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	58.63	35.43	13.50	29.11	0.84	0.42	1.27	2.11	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	44.25	23.46	12.26	23.99	1.60	0.53	2.13	2.67	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	75.22	35.05	14.29	19.71	1.65	1.50	3.16	1.65	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	83.67	40.76	18.31	18.58	2.54	1.47	3.34	1.07	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	95.81	35.56	15.71	22.61	1.38	0.86	2.76	2.07	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	83.89	33.48	15.77	18.48	1.94	1.29	2.59	2.20	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	101.68	34.46	17.71	31.06	2.67	1.46	3.40	3.15	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	169.76	44.12	19.09	36.38	3.10	2.32	3.61	2.32	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	130.40	36.08	17.72	25.64	1.27	1.58	3.17	1.90	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	131.87	29.67	16.48	45.61	2.20	1.10	0.55	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	257.21	36.54	22.63	47.86	3.06	0.94	2.59	4.72	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	203.04	29.72	19.87	42.16	1.78	0.97	1.94	4.36	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	238.15	36.19	22.44	52.84	2.90	2.35	2.35	4.52	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	334.11	37.68	16.12	81.64	2.51	1.05	5.02	7.12	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	326.48	35.95	22.47	78.15	2.54	0.98	0.98	5.08	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	244.37	34.19	14.77	85.04	2.32	1.06	1.90	6.33	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	145.64	18.47	12.87	85.77	0.66	1.15	1.15	9.24	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	298.44	29.73	20.19	80.22	0.93	1.31	3.74	7.11	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	366.19	41.39	16.29	91.60	3.45	0.96	4.41	4.60	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	322.92	38.63	21.26	93.61	2.04	0.82	3.47	10.22	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	323.59	34.05	18.94	60.65	2.01	0.60	3.83	7.66	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	368.69	35.38	17.02	91.02	1.35	1.89	1.62	5.40	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	398.74	38.65	18.96	78.50	2.16	0.72	2.40	8.16	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	355.71	32.70	18.35	76.22	1.88	0.71	2.82	7.53	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	188.70	22.25	16.69	76.42	1.90	0.88	1.17	9.66	2.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	442.45	44.71	23.20	93.00	2.53	1.90	3.16	4.85	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	477.10	43.53	22.38	95.98	1.92	1.75	3.50	7.17	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	460.97	39.15	24.70	87.34	2.61	1.61	2.81	7.23	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	468.08	41.41	22.10	105.16	2.09	0.70	2.79	10.47	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	536.43	46.06	23.51	100.76	3.36	1.20	3.36	6.96	3.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	450.95	36.66	16.99	77.49	3.28	0.60	1.49	6.86	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	540.99	41.17	24.89	119.45	3.59	1.68	3.83	7.18	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	440.99	29.32	22.85	97.66	3.44	2.02	1.82	6.47	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	387.36	36.89	30.54	112.52	3.07	1.43	3.07	8.40	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	526.36	45.81	29.80	174.34	2.22	2.00	2.45	7.56	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	223.87	13.99	0.00	11249.71	0.00	0.00	0.00	97.95	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	491.83	41.52	29.81	224.98	1.42	1.06	0.71	7.10	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	391.70	27.17	31.48	141.50	1.99	2.32	2.65	6.96	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	63.76	9.23	11.75	510.07	0.00	0.00	0.84	44.46	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	118.03	12.86	18.37	144.66	0.92	0.00	0.46	16.99	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	415.18	40.19	36.95	223.63	4.21	3.24	1.94	6.48	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	536.35	43.68	33.08	258.22	1.28	2.89	2.25	5.14	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	136.42	26.40	28.92	197.09	1.57	0.31	0.94	20.75	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	421.62	38.78	39.48	260.16	3.53	5.64	0.00	4.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	361.15	43.18	25.24	232.17	3.36	1.12	1.68	6.17	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	70.06	28.66	23.09	461.76	2.39	1.59	2.39	23.88	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	125.37	29.56	36.69	152.90	1.36	1.36	1.70	12.23	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	448.07	59.46	50.04	272.93	6.17	4.55	3.90	4.22	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	364.21	63.54	40.82	191.69	4.61	3.55	4.61	3.55	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	16.16	16.16	12995.80	0.00	0.00	0.00	64.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	157.95	0.00	23.69	5844.14	7.90	0.00	0.00	39.49	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	259.36	35.10	42.41	161.86	2.44	1.46	0.49	4.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	243.47	33.22	33.22	125.46	0.50	0.50	0.99	7.93	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	146.83	26.27	30.96	95.70	2.35	2.35	1.88	1.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	90.08	30.14	34.77	89.42	2.32	1.99	1.66	2.98	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	244.07	47.95	34.96	155.29	3.71	2.47	1.55	3.09	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	260.19	45.56	39.14	157.46	3.06	2.14	2.75	2.75	0.00
Adipocyte - breast, donor1	11376-118A8	114.04	16.00	17.58	26.29	0.63	0.79	1.43	1.74	3.96
Adipocyte - breast, donor2	11327-117E4	60.16	14.28	10.59	11.39	0.80	0.64	0.80	1.28	0.80
Adipocyte - omental, donor1	11473-119C6	142.11	18.32	14.89	16.54	0.89	0.89	0.89	3.05	3.56
Adipocyte - omental, donor2	11474-119C7	79.98	17.19	9.72	10.46	0.75	1.49	0.75	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	50.91	14.40	9.71	10.72	0.67	0.33	1.67	0.67	1.00
Adipocyte - perirenal, donor1	11476-119C9	108.46	13.40	7.66	33.18	0.00	1.91	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	47.28	9.90	11.00	6.60	1.10	0.00	0.00	2.20	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	22.13	8.13	10.84	2.26	0.45	0.45	1.81	0.45	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	13.73	17.90	7.82	2.26	0.52	0.35	0.70	0.17	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	138.66	40.68	26.01	13.89	1.76	0.98	1.37	0.59	1.56
Adipocyte differentiation, day04, donor2	13022-139D7	170.38	31.66	17.76	9.52	1.03	2.06	1.29	1.03	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	51.85	39.03	14.77	10.87	3.07	1.39	0.28	1.39	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	42.91	27.04	18.22	6.47	0.00	1.18	2.94	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	25.98	18.02	8.85	3.78	1.53	1.21	0.80	0.56	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	37.76	20.01	11.62	9.04	0.97	2.58	0.97	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	22.93	12.26	12.80	7.46	0.53	1.07	1.07	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	16.69	15.58	6.68	5.56	0.56	0.56	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	19.13	14.14	6.24	4.57	0.83	0.42	1.25	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	31.14	19.34	6.78	5.53	0.75	0.75	1.26	1.76	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	23.56	9.16	5.24	4.91	0.00	0.65	0.65	0.33	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	11.27	7.31	7.61	2.44	0.91	0.00	0.91	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	104.31	47.96	15.47	23.43	1.55	3.54	1.77	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	31.56	43.75	13.98	8.96	2.51	2.51	3.23	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	75.47	26.36	20.37	16.77	2.40	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	162.99	65.13	47.85	37.78	17.63	9.36	1.44	0.72	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	120.49	48.53	48.53	43.51	13.39	13.39	3.35	5.02	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	85.06	41.91	33.28	31.43	8.01	4.31	1.03	0.62	0.62
Anulus Pulposus Cell, donor1	11248-116E6	86.28	20.02	20.71	21.74	1.03	0.57	1.60	1.14	0.69
Anulus Pulposus Cell, donor2	11463-119B5	119.02	22.53	14.94	20.82	1.71	0.24	2.94	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	35.49	17.07	6.29	28.31	1.80	1.80	0.00	1.35	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	46.89	14.76	4.78	27.79	0.43	0.43	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	25.68	17.12	6.42	25.68	0.00	0.00	0.00	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	37.96	15.84	5.98	23.61	1.20	0.30	1.79	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	39.20	11.38	2.53	25.29	0.00	0.00	2.53	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	38.28	18.48	7.26	25.08	0.66	1.32	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	38.01	16.24	9.10	18.52	1.95	0.97	0.97	1.62	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	30.58	14.56	8.25	21.36	0.00	0.97	0.00	2.91	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	39.79	17.82	9.50	27.91	0.00	1.78	1.19	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	38.42	13.94	11.68	30.13	1.88	0.75	1.13	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	28.30	10.16	5.81	25.40	1.45	2.18	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	41.37	21.31	8.78	21.31	1.25	0.00	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	60.62	25.04	11.04	14.50	1.81	1.65	1.15	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	35.48	21.84	8.19	16.38	1.36	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	53.53	19.15	8.14	23.07	0.90	2.11	0.45	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	31.08	14.47	11.79	26.79	0.54	1.61	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	48.56	22.86	10.01	20.97	0.94	0.57	2.27	1.32	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	44.90	27.26	9.89	24.86	1.07	0.53	0.53	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	55.60	19.51	8.78	19.51	0.98	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	38.65	20.40	9.29	21.23	1.33	1.49	2.16	0.66	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	31.22	21.61	6.00	31.22	1.20	2.40	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	63.72	31.86	14.16	7.08	3.54	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	45.11	24.87	11.49	19.38	0.69	1.03	1.20	0.17	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	8.39	4.19	25.17	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	24.27	13.11	9.22	17.96	1.46	1.94	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	52.36	21.25	9.49	22.01	0.76	0.76	1.52	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	35.13	18.17	13.33	25.44	0.00	2.42	0.00	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	30.78	14.82	10.26	26.22	1.14	1.14	0.00	2.28	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	43.82	21.38	9.62	19.45	1.07	0.86	1.50	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	37.42	22.20	7.74	20.39	1.55	2.58	0.26	1.03	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	34.72	15.48	9.85	22.99	0.94	1.41	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	49.20	23.15	5.79	22.19	1.29	0.00	0.96	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	38.53	18.55	7.85	34.25	1.43	2.14	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	33.93	14.62	4.09	13.45	2.34	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	54.80	19.57	11.14	23.78	2.11	0.90	1.20	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	46.33	9.50	11.88	34.45	1.19	0.00	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	39.16	23.39	7.63	24.92	0.00	0.00	1.02	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	56.54	19.61	8.66	30.05	2.29	0.51	0.76	1.53	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	41.30	14.61	4.45	27.96	1.27	0.64	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	32.37	20.28	8.20	20.28	0.00	0.00	0.43	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	49.11	21.38	7.41	25.40	0.64	1.69	1.91	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	39.73	16.53	7.25	21.75	2.61	0.58	1.16	1.16	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	53.85	25.51	12.28	20.78	0.00	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	45.09	21.87	9.66	20.34	1.86	1.53	1.86	1.70	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	53.28	18.53	6.95	27.80	0.00	4.63	0.00	6.95	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	40.14	14.79	6.34	29.58	0.00	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	57.25	19.73	11.15	23.80	2.14	1.50	2.14	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	46.93	24.07	10.23	25.87	1.20	3.01	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	34.26	16.77	13.12	34.26	1.46	0.73	1.46	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	62.30	19.54	9.20	29.19	1.15	1.15	0.69	1.84	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	48.46	28.05	7.65	40.80	0.00	2.55	0.00	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	63.30	22.12	9.92	26.95	2.03	2.29	0.51	1.02	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	67.92	20.64	9.70	26.01	2.06	0.62	1.65	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	53.24	22.64	8.57	28.76	2.14	1.84	0.61	1.53	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	54.02	21.03	10.04	36.81	2.87	1.43	1.43	1.91	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	76.50	24.83	9.98	33.93	0.44	1.11	0.44	1.77	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	44.25	9.15	6.10	32.04	3.05	0.00	1.53	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	42.65	15.51	11.08	28.25	1.66	1.66	2.77	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	62.49	28.07	14.56	34.16	3.18	1.32	2.65	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	49.79	22.90	11.27	31.62	0.73	0.36	0.36	1.09	0.00
Astrocyte - cerebellum, donor1	11500-119F6	35.13	26.65	10.69	4.05	3.32	0.86	1.47	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	37.48	28.75	11.30	6.68	2.23	0.68	1.71	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	39.43	30.83	15.31	15.94	1.89	0.42	1.89	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	22.31	12.55	5.93	10.81	1.05	0.35	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	27.02	19.09	13.10	8.41	0.49	1.29	0.97	0.65	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	28.34	31.03	11.93	5.52	1.94	2.68	0.45	0.45	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	10.32	39.57	9.98	3.90	1.95	3.21	2.06	0.57	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	11.65	43.85	8.77	2.51	1.38	3.51	0.75	0.13	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	10.47	40.63	7.06	4.44	1.71	3.07	2.05	0.68	0.23
Basophils, donor1	12241-129G9	24.06	85.52	61.46	15.43	4.18	4.97	1.31	1.57	0.26
Basophils, donor2	12242-129H1	27.42	100.30	75.41	21.65	3.25	6.86	1.44	1.08	0.00
Basophils, donor3	12243-129H2	50.42	74.82	66.59	16.76	4.56	6.76	1.18	0.59	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	70.93	27.81	19.40	15.31	4.53	3.23	0.43	0.65	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	68.58	19.66	19.66	10.06	3.66	0.91	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	21.52	21.52	21.52	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	36.40	14.44	10.04	18.83	3.14	2.51	1.88	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	76.94	37.85	15.80	7.28	6.24	1.04	2.29	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	54.58	27.17	15.43	37.77	2.07	2.76	1.84	1.61	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	26.45	16.73	14.22	8.28	2.34	1.80	1.08	0.90	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	8.35	25.66	7.83	3.81	1.55	1.03	1.24	0.41	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	10.48	27.02	8.38	10.01	1.16	1.63	0.93	0.23	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	2.56	20.47	7.99	4.16	0.96	0.32	0.64	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	31.03	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	55.23	78.90	73.26	11.83	5.64	7.33	0.56	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	79.25	128.06	95.58	17.08	9.84	8.35	2.41	1.48	0.19
CD14+ Monocytes, donor3	11381-118B4	65.20	110.21	77.50	14.71	6.81	7.90	1.54	0.66	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	34.53	35.38	14.44	10.19	3.40	3.40	2.55	0.85	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	45.11	46.25	15.54	14.40	0.76	2.27	2.65	1.90	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	50.30	52.60	16.11	8.88	1.64	4.60	3.29	0.33	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	22.41	52.18	20.09	7.95	4.05	4.63	1.16	0.87	2.60
CD14+ monocytes - mock treated, donor2	11873-125C1	15.69	39.23	18.41	2.72	3.02	3.62	0.30	0.91	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	21.08	48.09	21.32	4.26	3.55	3.79	0.95	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	27.62	75.83	20.76	8.37	3.01	4.69	2.18	0.33	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	30.36	46.37	15.73	2.76	4.14	4.69	1.38	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	45.37	45.62	20.83	5.45	3.22	3.72	2.23	0.99	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	22.91	42.29	17.03	8.42	3.33	3.33	1.57	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	17.80	40.42	17.63	3.38	2.49	3.03	1.42	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	26.55	33.30	20.24	5.44	2.83	2.39	0.65	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	89.44	73.28	32.78	17.79	5.15	5.85	2.11	1.87	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	76.04	64.42	39.07	7.92	5.28	6.86	0.53	1.58	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	107.61	49.92	25.52	13.31	4.44	2.22	0.00	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	20.53	62.18	19.19	9.37	3.42	3.87	1.78	1.34	1.93
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	16.96	34.52	12.17	3.19	4.19	2.79	0.80	0.20	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	19.15	31.65	16.24	5.20	2.50	1.46	0.62	0.00	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	110.05	94.95	24.02	26.54	6.41	6.86	3.43	2.29	2.52
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	86.18	63.56	28.73	4.52	7.46	4.98	0.68	0.90	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	127.45	51.50	26.62	14.40	5.67	6.11	1.31	0.87	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	20.98	48.96	18.02	3.77	2.15	4.57	1.61	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.00	39.43	18.32	2.44	2.62	4.88	0.70	0.87	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	18.94	41.24	26.09	4.63	2.95	2.95	0.84	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	131.72	124.74	29.58	27.01	11.76	9.00	3.86	2.20	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	150.07	104.27	25.01	6.34	8.81	5.64	1.76	1.06	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	207.52	92.13	23.69	14.48	4.39	5.26	3.07	1.75	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	18.31	38.01	17.96	10.29	2.79	4.36	1.57	0.52	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	17.47	33.08	17.10	3.35	2.60	2.97	1.12	0.37	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	18.32	33.19	23.93	5.17	1.51	1.72	0.65	0.22	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	106.88	102.78	24.98	19.25	6.55	4.91	2.87	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	113.35	76.03	26.89	8.11	4.40	3.94	0.93	1.62	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	128.76	68.67	25.29	14.62	3.48	4.87	1.86	0.70	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	9.81	27.68	14.39	4.36	1.31	1.74	0.44	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	13.17	40.42	17.32	5.54	2.08	3.70	0.46	0.23	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	13.43	24.04	14.95	4.55	1.73	2.17	0.43	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	26.16	66.49	37.68	8.41	4.83	5.76	2.02	0.78	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	17.64	48.73	26.20	12.05	3.14	3.49	1.05	0.00	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	23.41	68.90	32.11	4.46	3.79	5.13	1.34	0.22	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	5.10	26.54	9.95	2.55	0.51	1.53	0.77	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	2.85	26.35	9.44	3.29	2.20	1.10	1.10	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	4.00	24.00	6.74	2.53	1.05	1.68	0.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	65.03	10.16	12.19	4.06	8.13	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	11.53	84.75	23.73	14.92	2.71	6.78	2.03	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	18.64	81.81	13.46	17.61	0.00	2.07	2.07	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	18.12	117.80	23.99	16.52	3.73	3.20	4.26	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	20.37	102.92	26.27	13.94	4.29	6.43	4.29	0.00	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.23	80.72	25.97	16.14	5.62	5.62	3.51	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	7.84	94.12	18.82	9.41	3.14	4.71	2.35	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	13.18	72.51	18.46	18.46	1.32	2.64	7.91	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	24.66	265.47	81.37	21.37	18.90	16.44	3.29	1.64	0.82
CD19+ B Cells, donor2	11624-122B4	28.29	184.26	96.48	18.14	14.51	13.06	2.90	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	34.33	229.19	75.72	28.27	18.17	16.15	8.58	0.50	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	8.49	12.53	6.87	2.83	1.21	0.81	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	9.99	6.79	5.99	4.39	0.00	0.40	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	6.02	24.10	10.04	2.01	2.01	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	15.73	37.08	22.47	6.74	0.56	2.25	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	8.64	16.16	10.90	7.89	0.00	0.38	0.75	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	3.83	15.33	11.50	5.41	0.00	0.00	0.23	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	10.35	108.55	12.14	10.00	3.57	2.86	5.71	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	8.57	135.94	20.82	11.02	3.67	3.06	4.29	1.22	0.61
CD4+ T Cells, donor3	11382-118B5	18.60	138.77	24.40	9.76	2.74	7.32	5.18	0.61	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1.53	22.72	3.06	2.81	1.28	1.79	0.77	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	3.14	53.23	7.86	7.86	1.80	3.37	1.57	0.67	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.86	31.33	4.02	3.16	0.86	1.15	1.44	0.00	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1.42	41.72	2.84	3.79	0.95	0.95	0.00	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	2.11	67.42	15.45	7.73	2.81	0.70	0.70	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	39.55	6.59	13.18	0.00	6.59	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	2.02	31.36	3.61	5.49	1.16	1.88	0.87	0.58	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	5.76	58.97	5.42	8.30	1.53	2.71	2.54	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	3.06	44.01	2.58	4.84	1.93	2.42	1.93	0.16	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	4.48	59.62	8.07	10.31	4.03	2.24	1.79	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	8.04	74.07	16.07	11.18	1.40	2.10	1.75	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1.32	47.96	7.92	3.96	2.20	0.88	0.88	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	2.53	27.83	3.37	2.53	0.84	0.42	0.00	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	2.49	41.14	5.19	9.56	0.62	1.87	1.25	0.62	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	1.00	28.40	2.00	2.67	1.00	1.34	1.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1.63	54.66	2.45	1.63	0.54	1.63	2.99	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	4.82	71.82	12.33	8.58	2.68	2.14	3.22	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	53.80	5.38	1.79	1.79	0.00	5.38	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	2.60	33.01	4.45	6.49	1.30	2.60	1.30	0.00	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	6.50	48.52	6.93	7.80	2.60	3.25	1.08	0.43	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	4.41	43.50	5.04	4.41	2.73	2.52	0.63	0.21	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	5.06	68.76	11.12	4.55	3.03	1.52	2.53	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	7.80	82.32	16.90	13.00	4.77	0.87	1.73	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	3.92	57.96	13.51	3.49	1.74	4.79	1.31	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	6.43	65.32	15.34	13.86	0.99	1.98	0.99	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	10.16	49.85	8.31	9.23	3.69	0.92	0.00	0.92	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	5.58	58.62	8.37	12.56	2.79	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	3.88	55.11	9.97	3.32	2.22	1.66	0.55	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	5.15	48.34	10.80	3.44	2.70	1.72	0.98	0.49	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	13.86	70.84	10.78	10.78	3.08	4.62	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	11.10	63.39	15.04	14.68	0.72	2.86	1.07	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	13.85	65.09	13.85	11.08	1.38	4.15	2.77	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	36.67	154.53	53.04	16.70	7.86	7.86	2.62	0.65	1.31
CD8+ T Cells, donor2	11307-117C2	27.78	164.81	48.81	16.52	4.51	10.51	3.00	1.13	0.75
CD8+ T Cells, donor3	11383-118B6	25.00	152.50	38.13	9.09	4.80	7.32	3.79	0.76	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	34.41	12.16	11.70	5.05	0.69	2.52	0.00	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	32.11	9.11	10.78	5.03	0.24	2.40	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	29.82	13.13	12.31	6.29	0.82	1.92	0.27	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	23.42	9.01	10.21	9.91	0.90	2.70	0.30	1.20	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	31.68	12.48	11.28	8.40	0.48	4.32	0.00	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	32.06	12.96	14.10	5.46	0.45	2.96	0.00	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	49.32	7.39	15.64	10.43	0.87	4.13	0.22	0.65	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	59.22	10.79	14.21	8.69	1.05	2.37	0.26	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	43.39	8.91	15.95	10.79	0.23	3.75	0.23	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	43.17	11.17	14.49	13.28	0.91	2.42	0.00	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	46.48	13.36	13.07	10.75	1.74	2.91	0.00	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	49.82	9.06	21.05	5.86	1.07	3.46	0.00	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	108.12	8.76	21.01	8.32	2.19	2.19	0.88	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	102.02	11.84	20.95	7.74	0.46	5.01	0.91	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	132.77	14.92	18.65	5.97	0.75	2.98	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	41.06	11.16	12.61	8.28	1.08	3.60	0.00	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	45.46	8.34	13.52	7.77	0.29	4.60	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	38.18	11.55	12.96	6.60	0.94	3.77	0.00	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	51.34	6.02	14.89	5.07	1.27	2.22	0.00	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	60.59	8.30	20.91	8.92	0.31	2.77	0.31	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	50.97	10.58	13.79	8.01	0.32	2.24	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	50.87	8.80	14.92	9.18	1.53	3.82	0.00	1.15	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	42.17	6.31	15.76	8.67	1.18	5.12	0.00	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	36.31	9.83	15.13	9.08	2.27	3.03	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	69.86	13.65	27.30	8.03	4.01	3.21	1.61	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	69.24	17.49	30.08	11.89	1.40	4.20	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	69.12	7.01	25.04	8.01	2.00	6.01	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	69.45	5.48	43.87	3.66	0.00	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	68.18	13.34	16.30	15.81	2.47	0.49	0.49	1.48	0.49
Cardiac Myocyte, donor3	11686-122I3	135.22	18.10	28.41	17.99	0.42	0.95	1.89	0.53	0.21
Chondrocyte - de diff, donor1	11261-116G1	183.39	12.48	19.41	33.97	0.35	0.35	0.00	1.39	2.08
Chondrocyte - de diff, donor2	11338-117F6	123.32	22.74	18.48	29.14	0.36	0.36	0.36	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	154.63	17.75	21.39	50.75	1.02	0.11	1.37	2.73	2.50
Chondrocyte - re diff, donor2	11339-117F7	304.39	28.65	32.23	38.50	0.00	0.00	0.00	0.00	4.48
Chondrocyte - re diff, donor3	11411-118E7	126.58	23.46	29.52	20.22	0.81	1.21	1.21	2.02	3.24
Ciliary Epithelial Cells, donor1	11242-116D9	7.34	18.48	7.46	3.79	0.46	0.57	0.23	0.23	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	5.99	16.03	6.84	6.63	0.86	0.86	0.64	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	8.05	15.40	5.40	2.83	0.62	0.80	0.62	0.27	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	53.83	34.20	15.77	7.52	2.57	1.74	2.84	0.55	0.64
Corneal Epithelial Cells, donor1	11526-119I5	76.19	29.20	27.45	13.83	4.17	4.61	0.66	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	61.43	18.20	17.06	28.44	2.28	3.41	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	30.42	22.75	14.32	7.92	3.83	5.37	0.77	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	29.22	20.14	5.28	9.58	0.50	1.82	0.99	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	30.59	16.09	6.62	5.36	0.95	1.58	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	6.90	3.45	0.00	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	25.81	15.01	4.86	3.35	0.86	2.05	0.54	0.32	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	151.35	225.14	132.22	47.83	15.03	15.03	5.47	1.71	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	100.54	136.45	84.87	18.93	10.45	6.53	5.22	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	109.37	139.86	109.37	16.94	14.03	4.84	2.90	1.94	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	9.67	17.34	6.84	8.84	0.50	1.00	0.67	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	5.87	21.12	7.04	1.76	0.00	0.59	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	11.31	27.43	8.20	2.83	2.55	0.57	1.13	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	10.62	18.09	5.90	1.57	0.00	1.57	1.18	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	12.22	35.78	11.34	4.07	2.91	1.45	1.75	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	11.06	25.17	10.12	5.88	2.59	2.82	2.59	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	11.57	22.09	7.71	7.19	1.58	1.40	1.23	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	2.66	16.62	5.98	3.55	0.44	1.11	1.11	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	4.26	20.99	3.96	1.83	0.61	2.13	0.30	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	3.66	20.58	5.07	0.85	0.56	1.69	1.13	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	12.78	23.47	5.35	7.73	0.59	1.19	1.49	0.59	2.08
Endothelial Cells - Microvascular, donor2	11342-117G1	8.33	22.91	3.64	6.25	0.52	0.52	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	6.24	32.33	4.40	5.53	1.28	0.28	1.70	0.57	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	10.00	24.41	7.60	5.60	3.20	2.00	0.40	0.40	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	4.72	28.83	9.43	3.67	0.00	1.05	1.05	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	10.31	26.46	8.08	10.06	1.37	0.99	2.11	0.25	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	9.34	24.12	10.86	3.48	0.43	1.30	0.22	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	10.87	24.43	9.65	0.37	1.10	2.69	1.10	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	7.96	18.20	3.41	0.00	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	5.59	15.37	6.29	0.70	0.00	2.10	2.10	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	7.54	20.88	7.07	5.81	0.94	1.41	1.26	0.16	0.00
Eosinophils, donor1	12244-129H3	0.00	152.47	30.49	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	110.57	382.86	186.48	28.05	16.50	37.96	3.30	6.60	1.65
Eosinophils, donor3	12246-129H5	128.41	406.62	153.37	64.20	32.10	35.67	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	66.46	25.65	20.77	10.99	4.89	2.93	1.22	0.24	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	62.40	31.20	8.32	8.32	6.24	2.08	2.08	2.08	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	113.88	48.81	32.54	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	141.63	20.12	22.99	19.70	0.82	1.64	0.41	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	209.89	18.18	12.59	33.83	1.86	0.88	0.77	7.45	3.39
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	25.24	10.18	2.49	4.12	1.73	0.33	0.98	0.43	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	109.15	16.98	18.80	25.35	1.21	0.73	0.24	2.30	3.40
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	232.27	20.20	19.11	24.29	1.09	0.41	0.68	0.82	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	231.82	20.57	21.62	54.32	0.74	1.16	1.48	2.95	4.96
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	343.33	26.35	55.86	42.16	1.58	0.53	0.79	3.69	9.22
Fibroblast - Aortic Adventitial, donor3	11401-118D6	89.36	18.60	19.27	18.94	1.00	1.99	0.66	0.66	1.00
Fibroblast - Cardiac, donor1	11268-116G8	141.99	18.15	15.42	14.52	1.36	0.00	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	184.18	19.71	21.98	34.87	0.76	3.03	0.76	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	49.84	21.45	12.93	5.52	2.05	1.73	0.95	1.10	0.95
Fibroblast - Cardiac, donor4	11452-119A3	73.05	19.10	24.25	8.18	1.21	1.52	0.61	0.61	0.30
Fibroblast - Cardiac, donor5	11456-119A7	76.02	19.80	19.42	9.64	1.27	1.52	1.90	1.40	0.89
Fibroblast - Cardiac, donor6	11460-119B2	39.87	18.34	14.10	12.13	1.82	1.21	1.06	0.15	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	14.87	26.66	12.19	2.41	1.21	0.67	0.94	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	15.96	21.57	13.37	1.29	2.16	0.00	1.29	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	27.83	19.04	20.51	13.18	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	61.81	32.98	28.60	5.77	3.92	1.61	0.69	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	49.02	13.23	19.50	4.07	0.51	0.00	1.02	0.51	0.68
Fibroblast - Dermal, donor1	11269-116G9	7.28	8.69	5.17	2.11	0.94	0.47	0.00	0.00	0.47
Fibroblast - Dermal, donor2	11346-117G5	8.49	9.91	2.36	4.25	0.47	0.47	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	7.98	11.12	6.77	3.99	0.36	1.09	1.09	0.48	0.00
Fibroblast - Dermal, donor4	11450-119A1	12.21	17.07	8.82	4.07	1.13	0.90	0.90	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	14.48	16.75	11.34	8.20	0.87	0.52	0.87	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	11.86	16.57	8.93	7.80	1.14	1.46	0.81	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	29.78	14.99	13.53	13.74	1.25	0.62	1.25	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	74.41	12.05	25.15	10.22	0.52	1.05	0.26	0.26	1.31
Fibroblast - Gingival, donor2	11318-117D4	11.33	12.91	8.43	4.09	1.05	1.45	0.53	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	56.76	17.31	18.08	9.28	1.26	1.45	0.48	0.29	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	193.23	19.74	38.44	41.56	1.04	1.04	1.04	1.04	6.23
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	104.14	17.97	22.73	16.56	1.06	0.53	1.06	2.47	1.41
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	45.37	12.47	13.10	7.79	1.25	0.94	0.47	0.16	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	36.78	8.38	10.68	5.27	1.22	0.41	0.41	0.41	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	140.09	35.99	41.64	0.71	7.41	6.70	2.47	0.00	1.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	63.32	15.21	13.89	11.41	1.17	0.58	0.58	0.44	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	83.72	7.23	14.32	14.04	0.27	0.82	0.55	1.23	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	72.84	11.63	14.70	5.70	1.43	1.10	0.66	0.33	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	180.49	15.85	42.55	20.84	1.76	0.59	1.61	2.93	1.32
Fibroblast - Lung, donor1	11270-116H1	8.16	9.52	5.44	2.72	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	20.89	8.95	10.45	0.00	0.00	0.00	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	14.98	6.12	9.07	3.80	0.21	1.06	0.84	0.63	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	86.63	45.82	24.99	1.67	1.67	1.67	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	67.13	22.38	12.59	11.19	0.00	0.00	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	26.31	25.19	12.87	3.36	0.84	2.24	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	103.93	39.38	34.91	2.03	1.22	4.87	1.22	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	27.96	27.96	23.97	7.99	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	95.30	41.69	5.96	5.96	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	15.91	10.28	7.56	4.85	1.16	0.78	0.19	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	10.77	18.96	12.13	1.21	0.76	2.88	1.06	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	35.19	22.34	18.67	3.06	1.53	2.75	0.61	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	51.52	19.46	14.12	8.40	1.14	1.53	1.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	92.61	20.79	20.79	34.83	1.08	1.89	0.54	1.35	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	178.95	32.12	29.81	11.02	1.74	2.55	2.55	1.51	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	51.51	15.92	16.25	24.98	0.88	1.11	0.77	0.33	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	94.69	35.15	34.75	5.08	2.03	4.06	0.81	0.61	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	20.05	21.38	14.70	12.03	3.34	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.21	10.28	12.26	9.88	0.79	0.00	0.40	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	52.19	16.27	23.02	8.73	0.99	0.60	0.40	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	126.64	13.32	19.89	15.99	0.89	0.53	0.71	1.07	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	62.87	15.57	19.12	8.08	0.59	0.79	1.38	0.99	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	82.43	20.76	29.78	15.95	2.41	0.60	1.50	0.90	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	59.70	12.31	16.95	12.41	1.30	1.30	0.32	0.54	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	34.92	7.85	13.67	3.80	1.52	0.25	0.00	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	75.97	13.62	14.27	9.02	0.82	0.49	0.66	0.98	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	137.35	23.06	56.74	40.90	3.01	0.80	1.00	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	104.98	14.27	22.80	31.44	1.41	0.30	0.60	1.71	1.51
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	32.64	6.95	18.13	1.81	0.91	0.00	0.60	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	71.74	18.72	21.87	9.11	0.58	0.99	0.99	0.50	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	50.60	7.69	20.51	8.21	1.20	0.34	0.51	1.03	1.88
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	79.81	24.96	28.90	15.11	2.63	0.00	0.66	1.31	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	47.83	15.87	16.40	10.12	1.49	0.96	0.64	0.75	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	71.18	11.98	15.01	6.41	1.52	2.53	0.17	0.51	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	21.64	6.43	12.23	18.50	0.31	0.16	0.63	5.65	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	22.16	952.87	22.16	0.00	0.00	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	15.69	17.43	13.07	2.61	3.49	1.74	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	91.19	37.97	21.84	35.19	8.32	5.55	1.39	0.87	1.73
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	129.08	45.80	29.41	21.34	8.33	7.03	0.78	1.04	3.12
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	99.91	37.82	18.91	25.04	5.11	5.37	0.51	0.77	2.81
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	5.36	18.37	4.59	9.19	2.30	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	5.74	13.40	3.83	5.74	1.28	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	0.86	14.55	3.14	4.56	0.29	0.86	0.29	0.86	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	0.55	18.20	6.07	6.62	0.28	1.65	0.55	0.55	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	3.65	21.92	3.88	6.16	0.46	1.37	1.60	0.46	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	1.19	22.78	3.76	4.95	0.79	0.59	1.39	0.20	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1.59	12.42	2.11	5.82	0.26	1.06	0.00	0.53	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	5.22	24.46	5.54	8.15	2.28	0.98	0.65	2.61	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	1.77	16.80	0.88	7.08	0.88	0.88	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	4.24	12.44	4.38	5.94	1.13	1.70	0.71	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	5.05	13.92	3.94	2.59	1.35	0.74	0.49	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5.37	9.94	2.95	3.49	0.27	0.27	0.54	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	3.59	19.08	4.83	4.71	1.61	1.24	0.74	0.25	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	3.18	12.74	5.26	3.18	0.83	0.83	0.00	0.42	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	5.69	11.99	3.25	4.07	0.41	1.22	0.61	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	4.79	21.68	4.79	8.21	1.60	2.74	0.91	0.46	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	2.37	13.95	5.11	5.36	1.12	1.25	1.00	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	10.93	22.29	11.58	3.93	0.22	2.40	0.87	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	8.86	26.89	5.02	7.68	2.07	2.66	1.18	0.59	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	4.29	18.92	4.45	3.34	1.11	2.07	0.79	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	11.84	18.32	7.37	4.69	1.34	1.79	0.67	0.22	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	3.83	24.20	5.65	6.25	2.82	1.41	0.60	0.60	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	3.05	21.71	3.39	4.41	1.36	0.68	1.02	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	25.98	35.38	10.02	7.98	2.84	2.39	1.33	0.80	1.60
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	6.35	37.04	7.60	4.16	3.95	1.98	0.73	0.21	1.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	3.24	29.37	6.15	1.71	2.05	3.59	1.20	0.51	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	1.66	19.59	3.10	3.54	1.88	1.33	0.77	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.47	32.11	10.65	8.74	1.58	2.25	1.00	0.25	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	15.93	29.81	6.53	5.10	2.25	1.63	0.41	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	3.30	23.31	4.33	7.84	1.65	2.48	0.41	0.21	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	1.96	24.33	4.04	5.76	2.31	2.42	1.15	0.35	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	5.34	26.85	4.84	4.67	2.00	1.83	1.00	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	1.54	25.79	5.95	3.97	2.42	1.98	0.88	0.22	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	1.11	16.73	4.92	5.29	2.83	1.11	1.11	0.25	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.92	22.69	8.59	3.73	1.46	1.62	1.46	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	2.57	22.77	7.70	4.81	1.28	1.60	1.28	0.32	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	2.37	17.25	4.26	3.88	1.90	1.52	0.95	0.19	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	2.21	21.35	3.64	5.22	2.21	1.42	0.47	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	3.95	23.72	3.65	4.26	2.43	1.82	0.30	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	2.61	17.35	3.76	6.90	2.40	1.57	1.15	0.63	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	9.00	26.13	7.25	7.46	1.98	2.20	0.66	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	4.77	22.72	3.09	2.81	2.81	1.12	0.84	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	3.33	16.39	4.26	2.13	3.61	2.13	0.83	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	6.15	19.25	5.08	3.74	3.48	0.80	1.07	0.80	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	3.37	23.10	4.74	3.67	2.30	3.06	0.92	0.00	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	3.37	12.18	4.53	4.27	2.20	2.20	0.52	0.26	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	3.80	19.79	5.42	4.61	2.17	1.90	1.36	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	8.48	21.02	7.19	7.19	2.21	1.84	1.47	0.37	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	10.97	15.35	10.97	4.82	2.41	1.32	1.32	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	11.90	31.74	11.90	3.97	3.97	2.98	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	12.27	17.15	8.31	6.33	3.56	1.71	1.19	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	15.94	16.14	9.48	8.07	2.82	1.82	0.61	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	56.93	43.72	25.67	2.80	8.90	3.56	1.52	0.00	1.78
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	1.00	9.95	2.99	2.39	0.20	0.00	0.40	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	0.77	8.32	2.00	2.00	0.15	0.15	0.46	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	0.61	10.64	3.07	2.25	1.43	0.41	0.20	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	4.38	12.20	1.88	6.26	1.56	0.00	0.31	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	3.67	8.19	1.13	5.65	0.28	0.00	0.28	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	0.46	11.07	1.38	4.61	0.00	0.46	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	12.37	2.47	2.47	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	9.67	13.93	5.03	6.19	0.77	1.93	0.00	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	14.44	16.04	3.21	6.42	3.21	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	10.43	19.13	10.43	5.22	0.00	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	13.02	17.58	6.51	9.44	0.33	0.33	0.33	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	7.00	21.41	6.18	9.06	1.24	0.82	1.65	0.41	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	6.66	3.33	23.33	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.35	22.65	10.07	9.23	1.12	1.12	0.84	0.84	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	13.73	17.65	12.09	12.42	1.31	0.65	0.98	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	9.23	31.88	7.55	9.23	1.68	0.84	0.00	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	13.68	24.17	6.68	10.81	1.27	0.64	0.64	0.00	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	8.49	18.68	6.45	12.57	1.36	2.04	0.68	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	2.09	25.06	6.26	6.26	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	8.59	23.48	6.87	13.17	1.15	1.15	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	6.51	18.05	7.70	14.21	1.78	1.78	0.89	0.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	32.19	6.78	13.55	5.08	0.00	5.08	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	8.70	23.20	6.21	8.28	2.07	1.24	0.41	2.07	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	5.29	15.19	5.06	8.51	1.15	1.61	0.46	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	47.42	26.34	10.54	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	7.69	21.91	3.84	8.46	1.54	1.15	0.77	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	6.19	20.21	5.87	9.13	0.65	1.30	1.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	9.36	25.42	8.03	5.35	1.34	2.01	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	4.62	20.42	9.25	7.71	2.70	1.16	0.77	1.16	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	13.35	34.92	9.59	14.04	2.74	2.05	1.71	0.00	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4.97	22.36	9.94	4.97	0.00	2.48	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	2.83	28.31	10.38	6.13	0.47	1.42	0.94	0.94	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	3.62	24.74	6.03	11.47	3.62	4.22	0.60	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	6.61	35.10	8.14	6.10	2.03	3.56	2.03	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	4.39	27.12	5.58	9.97	3.19	1.20	1.99	0.00	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	4.93	34.04	8.39	9.37	1.48	0.49	0.00	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	4.72	33.05	7.08	10.62	2.36	0.00	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	2.92	25.67	9.34	18.09	1.17	1.17	0.00	1.17	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	5.27	26.33	6.14	10.09	1.76	2.19	1.32	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	3.39	29.67	6.78	8.48	0.00	1.70	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	4.18	20.30	4.18	7.76	1.19	0.00	0.00	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	2.43	22.81	7.76	3.88	0.97	0.49	2.91	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	278.48	39.95	34.24	21.68	3.42	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	95.22	29.11	16.22	30.77	4.16	3.74	0.42	1.66	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	44.98	20.24	10.12	1.12	2.25	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	36.79	15.86	14.59	14.91	0.95	0.32	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	22.98	18.38	7.10	5.01	1.25	0.00	0.42	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	145.98	15.55	12.88	17.52	3.13	2.09	1.16	1.04	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	150.57	14.18	12.83	16.04	3.21	4.39	0.34	1.35	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	160.84	13.20	15.24	15.24	3.64	2.73	0.68	0.91	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	139.92	14.54	13.34	21.32	4.04	1.86	0.66	1.86	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	152.59	14.40	13.32	12.25	3.65	3.22	0.43	1.07	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	157.80	16.15	11.84	18.30	5.17	1.51	0.43	1.29	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	116.32	17.06	9.84	16.81	4.98	2.86	1.25	1.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	115.11	14.41	11.67	14.24	3.43	2.23	1.20	1.72	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	119.18	9.93	8.65	10.25	4.49	1.28	0.64	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	7.28	23.50	5.04	5.04	3.36	1.12	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	20.34	33.76	13.42	13.42	3.46	3.03	0.87	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	31.73	5.29	23.79	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	65.61	22.22	23.99	18.69	0.71	1.76	1.41	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	51.58	18.89	13.08	13.08	0.73	2.18	1.45	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	44.58	14.34	17.13	30.60	1.22	1.22	0.35	0.70	0.00
Hepatocyte, donor1	11523-119I2	94.43	50.85	13.32	18.16	2.42	1.21	2.42	2.42	0.00
Hepatocyte, donor2	11603-120I1	137.90	53.87	15.08	23.70	2.15	0.00	2.15	0.00	3.23
Hepatocyte, donor3	11684-122I1	76.08	73.62	12.88	19.02	2.45	1.84	3.07	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1.31	9.14	0.00	0.65	0.00	0.00	1.31	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	47.72	46.32	19.23	9.44	4.37	5.42	2.97	1.57	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.72	19.76	7.41	6.72	1.51	1.65	0.55	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	25.47	9.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	13.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	4.15	1.38	1.38	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	2.50	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	10.25	10.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	4.57	4.57	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1.62	3.25	6.50	0.00	0.00	3.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	8.34	5.00	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	3.63	7.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	2.65	3.97	9.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	3.33	4.43	1.11	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	15.71	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	5.67	5.04	0.63	0.00	0.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	3.09	6.19	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	29.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.65	4.52	3.88	0.65	0.00	1.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1.61	8.05	8.05	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	3.26	3.26	11.41	0.81	2.44	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1.26	4.20	11.33	0.00	0.42	0.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1.61	4.82	8.04	0.00	0.80	0.80	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.92	5.54	4.62	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.94	1.89	5.19	0.00	0.00	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	1.81	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	3.23	8.61	0.00	0.00	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	6.35	7.62	2.54	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3.83	5.10	7.01	0.00	0.64	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	3.65	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	31.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2.14	2.86	6.43	1.43	0.00	1.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	3.32	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.93	4.32	2.78	0.93	0.62	0.93	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	5.27	5.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	12.57	3.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.70	3.48	2.78	0.00	2.09	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	8.85	13.28	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	3.24	16.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.87	9.59	5.23	0.00	0.00	1.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	9.00	4.50	0.00	0.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	10.45	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	3.20	14.93	5.33	0.00	0.00	0.00	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	5.54	8.31	0.00	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	8.55	2.85	0.00	2.85	5.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	4.60	3.68	7.36	0.92	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	15.13	9.08	0.00	3.03	3.03	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	12.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	2.11	8.46	3.17	1.06	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	39.25	41.04	10.53	6.04	6.28	3.75	1.71	0.90	1.71
Keratinocyte - epidermal, donor2	11349-117G8	33.97	23.43	9.37	9.37	4.69	3.51	0.59	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	29.91	24.04	11.74	5.30	4.07	3.60	0.38	0.47	0.19
Keratinocyte - oral, donor1	11251-116E9	50.17	33.37	28.15	22.48	3.75	5.11	2.16	0.68	0.57
Keratocytes, donor1	11527-119I6	38.51	13.75	27.16	4.81	1.03	1.03	0.69	0.00	0.00
Keratocytes, donor2	11607-120I5	15.23	16.41	10.55	3.52	0.00	3.52	0.00	0.00	2.34
Keratocytes, donor3	11688-122I5	24.11	8.50	15.61	2.96	0.79	0.79	0.00	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	15.39	57.15	26.37	6.59	0.00	0.00	8.79	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	6.47	23.73	5.39	16.18	2.16	0.00	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	7.15	30.10	3.69	2.77	0.81	0.81	1.61	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	22.60	27.25	17.86	2.12	1.11	2.42	0.91	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	69.96	46.01	11.26	16.25	1.54	2.49	2.49	0.71	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	37.68	27.35	7.54	37.12	2.23	0.84	1.40	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	56.83	42.97	10.70	20.94	2.20	1.89	2.68	1.57	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	28.50	27.42	8.60	13.98	1.61	1.08	0.00	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	43.49	34.04	8.82	34.98	0.95	0.63	2.52	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	36.98	28.25	7.98	18.76	1.62	1.83	2.26	0.97	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	25.03	24.62	9.03	17.65	2.05	1.23	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	28.82	25.03	9.86	29.33	1.01	2.02	2.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	48.98	34.91	10.98	21.11	0.99	1.41	1.83	1.13	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	31.64	21.75	5.54	20.17	1.19	1.19	1.98	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	46.34	31.60	9.50	35.09	0.78	1.16	2.91	0.78	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	32.22	27.22	7.78	21.48	1.11	2.04	1.67	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	37.28	27.53	7.67	21.25	0.35	0.00	1.74	0.70	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	52.71	31.72	9.06	28.62	1.67	0.95	1.91	0.72	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	49.86	35.16	10.71	21.29	2.20	0.69	1.92	1.24	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	35.72	25.56	7.39	23.40	0.92	1.54	2.46	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	34.92	22.45	8.73	34.60	0.94	0.62	1.25	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	46.66	39.53	12.81	23.06	1.65	0.73	2.56	1.46	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	36.86	32.58	7.24	22.38	1.65	1.32	2.30	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	38.37	26.94	12.01	37.19	2.05	2.64	1.76	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	44.56	31.12	11.95	21.16	2.24	0.25	1.00	1.49	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	32.49	21.82	9.21	25.70	0.97	2.91	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	31.78	28.01	6.73	30.43	1.89	1.35	2.69	0.81	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	51.77	38.60	13.32	21.50	1.82	1.51	1.82	0.76	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	41.47	18.66	5.18	27.99	0.52	0.00	0.52	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	46.07	30.78	9.00	36.43	1.05	1.47	2.30	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	52.33	38.50	12.33	18.80	2.26	2.56	2.56	0.60	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	40.58	30.27	8.94	41.96	1.38	1.38	2.75	1.38	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	38.57	27.28	9.22	28.41	1.69	0.94	1.69	0.19	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	44.21	33.51	10.07	19.19	1.70	1.70	1.80	0.64	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	42.64	19.38	8.24	25.20	1.94	0.48	0.97	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	47.96	28.78	10.59	32.42	2.65	1.32	1.32	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	47.57	36.05	10.53	20.44	1.49	1.61	2.23	0.74	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	44.43	31.10	10.74	20.73	2.22	2.22	0.37	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	46.20	24.96	8.89	32.61	0.99	0.74	1.48	1.24	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	46.75	31.90	12.24	16.50	1.24	2.34	1.92	1.10	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	34.74	24.44	8.04	22.51	1.61	1.61	1.29	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	41.08	29.22	9.43	31.95	0.61	1.22	1.83	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	46.89	35.27	11.34	19.04	0.84	0.98	2.52	0.56	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	30.93	22.04	7.82	14.58	2.13	2.13	1.42	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	43.63	28.12	9.21	28.12	0.97	1.45	2.91	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	48.55	27.70	13.54	19.30	1.71	0.62	1.87	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	32.23	25.78	7.88	19.34	2.51	1.43	0.36	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	43.12	29.73	11.43	19.93	2.29	0.65	2.29	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	35.08	28.49	6.59	18.60	0.71	1.65	0.47	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	71.53	39.85	12.75	15.35	1.49	2.72	2.48	0.87	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	42.26	25.87	10.25	24.08	1.02	0.77	2.56	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	41.77	26.55	12.53	12.53	1.49	2.09	1.79	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	4.53	9.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	26.08	6.14	3.84	2.30	1.53	0.00	1.53	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	17.81	0.74	5.94	0.00	2.97	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	33.85	8.04	5.50	6.77	1.69	1.69	0.42	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	27.43	1.41	2.81	2.81	1.41	2.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.95	3.74	8.41	1.87	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	26.79	2.06	3.61	7.73	0.52	2.06	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	24.98	1.19	4.76	1.19	2.38	0.00	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	41.62	5.20	4.98	2.71	1.81	1.58	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	40.13	3.20	4.07	11.05	0.58	0.87	0.00	1.45	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	33.76	6.30	4.05	3.60	0.00	0.90	0.00	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	55.28	6.91	8.13	4.47	1.76	1.22	0.00	0.14	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	31.84	8.22	6.16	5.65	1.54	1.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	45.52	3.88	7.41	6.00	2.47	1.41	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	24.65	3.33	6.00	0.67	0.00	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	35.66	8.66	8.15	3.57	0.51	2.04	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	39.22	6.14	5.34	5.34	2.40	1.33	0.27	1.07	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	34.20	5.29	6.61	7.37	1.13	1.32	0.38	0.94	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	34.97	6.14	3.68	5.52	0.00	2.45	0.61	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	41.59	4.89	9.79	3.26	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	42.27	7.50	6.66	9.58	1.04	1.04	0.21	0.62	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	37.27	6.17	6.17	14.01	1.40	1.12	0.00	1.12	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	43.27	6.18	6.18	5.15	2.06	0.00	0.00	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	38.03	7.84	4.94	11.61	0.87	0.58	0.00	0.87	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	35.87	5.08	5.08	8.37	1.20	0.90	0.30	1.20	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	49.24	3.32	7.19	6.64	2.77	2.21	0.00	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	49.13	6.36	6.72	8.48	1.06	1.77	0.35	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	39.83	7.74	5.16	7.38	1.84	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	44.90	3.45	4.61	4.61	0.00	0.00	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	45.67	6.52	8.06	6.14	1.54	2.30	0.38	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	39.06	4.53	6.79	9.06	1.13	0.57	0.00	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	46.77	1.64	7.38	4.92	0.00	1.64	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	50.16	10.39	7.68	6.78	1.81	1.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	37.34	4.31	8.62	7.90	1.44	5.03	0.00	2.15	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	46.31	7.47	8.96	3.73	0.00	0.00	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	39.39	4.83	5.95	5.95	2.60	1.86	0.00	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	32.74	2.58	5.17	9.48	2.58	1.29	0.43	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	37.68	5.14	10.28	3.43	0.86	1.71	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	41.31	5.66	8.00	4.00	0.67	1.33	0.00	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	33.18	6.64	3.62	3.62	1.21	0.60	0.00	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	34.13	4.27	4.98	3.55	0.71	0.71	0.71	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	27.15	5.84	9.62	5.50	1.03	1.03	0.34	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	37.04	2.68	4.83	7.51	2.15	2.68	0.00	1.61	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	32.32	1.35	6.06	3.37	0.67	3.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	37.41	4.44	8.15	8.89	0.37	0.74	1.11	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	4.65	6.98	3.49	1.16	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	31.73	5.29	2.12	4.23	1.06	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	39.21	3.20	5.60	8.40	0.80	0.00	0.80	1.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	43.61	6.54	2.91	2.91	3.63	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	49.06	8.43	6.90	3.07	2.30	1.53	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	37.98	6.91	6.91	4.44	3.45	2.96	0.00	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	33.87	4.70	5.65	3.76	1.88	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	52.80	8.55	11.06	2.01	2.01	2.01	1.01	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	51.37	5.41	8.11	7.21	3.15	2.25	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	58.52	1.72	3.44	8.61	0.00	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	51.21	6.23	7.13	3.56	1.78	0.45	1.34	1.78	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	56.70	10.56	6.65	5.47	1.96	1.17	0.78	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	34.97	6.60	5.94	11.22	1.32	1.32	0.00	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	49.30	5.71	9.34	3.11	4.15	2.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	32.82	5.69	7.88	5.25	0.44	0.88	0.00	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	41.93	6.15	2.80	5.03	0.56	0.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	56.97	5.74	7.51	6.62	1.77	1.77	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	44.74	7.33	8.49	7.71	2.70	2.31	1.16	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	47.09	5.06	4.05	6.08	0.51	1.01	0.00	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	46.62	6.73	8.17	4.33	1.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	48.50	3.18	3.98	7.55	0.80	1.99	0.80	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	48.00	6.68	7.29	5.47	1.82	1.82	0.00	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	28.36	4.84	2.08	6.23	0.69	0.00	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	46.74	6.08	7.60	8.36	2.28	1.52	0.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	54.74	7.75	4.13	11.36	1.55	1.03	1.03	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	29.63	4.84	7.86	1.81	1.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	49.44	6.97	5.70	8.56	1.90	1.58	0.32	1.27	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	52.78	8.00	3.73	4.26	2.13	1.07	0.53	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	39.08	5.17	6.90	4.60	3.45	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	50.39	5.14	6.69	6.69	2.06	1.54	1.03	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	51.64	12.03	3.54	16.98	2.83	1.41	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	49.94	3.97	9.65	7.94	2.27	1.13	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	47.84	5.41	6.24	6.66	2.91	1.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	64.99	5.48	10.18	7.83	0.00	1.57	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	43.01	6.68	4.59	5.43	1.67	0.84	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	65.98	9.76	6.97	5.58	1.86	2.79	0.46	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	57.54	9.37	3.35	10.04	0.00	1.34	0.67	2.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	52.93	8.02	3.21	3.74	1.07	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	50.92	5.25	6.06	3.23	0.81	2.02	0.00	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	54.15	6.42	2.75	7.34	1.84	3.67	0.00	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	45.34	4.45	5.33	5.33	2.67	0.89	0.00	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	68.95	8.55	4.56	2.28	0.57	2.28	0.00	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	55.98	6.14	6.14	8.44	0.77	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	42.13	6.02	3.83	4.92	0.00	0.00	0.00	1.64	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	50.34	6.24	4.45	5.79	0.00	0.89	0.00	0.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	58.49	10.14	5.72	1.04	1.04	1.56	1.04	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	39.79	3.98	6.63	1.99	1.33	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	4.16	6.24	6.24	6.24	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	19.14	36.69	5.01	7.29	1.37	3.65	2.51	0.68	0.23
Macrophage - monocyte derived, donor2	11313-117C8	39.64	22.20	6.06	10.83	0.37	2.57	1.28	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	30.41	32.90	7.86	5.90	1.05	2.10	3.01	0.52	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	34.52	22.30	9.56	10.62	2.12	3.19	1.06	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	95.39	35.02	30.26	25.83	4.91	3.49	0.95	1.43	0.63
Mallassez-derived cells, donor3	11930-125I4	53.09	26.13	17.65	19.60	2.64	4.59	0.14	0.56	0.56
Mammary Epithelial Cell, donor1	11273-116H4	82.21	23.12	27.00	39.46	3.99	2.09	0.50	1.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	55.59	21.72	19.69	9.84	4.63	2.90	0.87	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	25.94	9.98	14.72	5.49	1.25	4.74	0.50	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	59.66	10.17	19.66	1.36	1.36	2.03	0.00	1.36	0.68
Mast cell, donor1	11563-120D6	12.00	33.63	11.90	5.73	0.65	2.27	1.08	0.22	1.62
Mast cell, donor2	11565-120D8	110.85	123.92	74.89	20.51	6.54	9.51	4.75	2.97	2.67
Mast cell, donor3	11566-120D9	37.60	105.81	52.68	12.38	3.15	8.10	3.15	2.93	1.13
Mast cell, donor4	11567-120E1	63.82	81.02	43.97	14.01	2.30	6.38	3.72	1.60	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	13.53	24.40	13.97	4.99	1.22	4.21	0.78	0.44	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	43.19	14.01	18.68	12.26	0.58	1.75	0.00	1.17	3.50
Mast cell, expanded, donor5	11939-126A4	0.92	23.52	5.39	5.62	0.92	1.61	0.69	0.11	0.92
Mast cell, expanded, donor8	11941-126A6	11.38	33.64	13.56	7.53	0.84	4.18	1.51	0.33	0.67
Melanocyte - dark, donor1	11502-119F8	4.58	34.92	3.88	3.38	1.09	0.80	2.49	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	73.37	13.84	22.15	16.27	0.35	0.35	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	8.19	22.67	4.13	4.35	2.32	3.11	0.80	0.14	0.14
Melanocyte - light, donor1	11274-116H5	10.11	19.04	5.88	0.71	2.59	3.29	0.47	1.41	1.18
Melanocyte - light, donor2	11351-117H1	3.41	19.11	2.73	0.00	0.68	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	8.67	8.67	7.81	6.94	1.73	3.47	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	8.02	18.64	5.73	4.69	2.92	2.60	0.94	0.21	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	7.53	16.14	4.03	6.19	3.23	1.61	0.81	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	2.14	16.34	2.95	7.50	3.48	1.34	0.27	1.34	0.54
Meningeal Cells, donor1	11493-119E8	8.56	21.83	8.44	2.48	1.24	0.50	0.99	0.00	0.25
Meningeal Cells, donor2	11573-120E7	5.72	20.69	7.92	4.40	0.44	1.32	2.20	0.00	0.00
Meningeal Cells, donor3	11654-122E7	7.42	15.32	6.19	4.48	0.57	0.98	0.73	0.08	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	15.97	14.26	8.27	6.56	0.29	0.86	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	75.57	19.93	13.89	9.26	1.81	1.61	1.21	0.50	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	18.40	13.14	14.46	0.00	2.63	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	13.08	13.08	15.70	10.47	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	13.63	7.89	15.79	5.74	1.44	0.00	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	23.72	16.31	13.13	4.45	1.06	1.91	0.64	0.42	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.11	11.56	12.57	4.52	2.01	1.01	0.00	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	30.99	18.02	13.19	9.89	1.98	1.32	1.10	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	21.92	8.77	9.50	2.19	0.00	0.00	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	17.19	18.21	9.62	6.55	0.82	1.02	0.61	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	80.89	27.70	17.87	18.01	1.39	1.25	1.94	0.42	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	98.14	35.69	26.02	14.50	1.49	0.00	1.12	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	89.21	26.45	31.45	23.29	0.79	1.45	1.32	0.79	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	70.33	44.81	24.04	6.83	1.48	4.45	2.67	0.89	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	46.71	11.68	25.69	23.36	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	61.48	45.47	20.49	9.61	1.92	3.84	3.20	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	12.05	10.63	9.22	8.15	1.06	1.77	0.35	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	52.22	16.26	20.95	18.14	0.63	1.56	1.25	0.94	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	42.09	26.85	23.95	15.24	2.18	2.18	2.18	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	454.25	42.16	21.74	50.65	3.18	2.65	1.86	5.04	7.69
Mesothelial Cells, donor2	12156-128G5	84.58	18.02	12.01	19.52	1.00	2.50	2.00	1.50	0.50
Mesothelial Cells, donor3	11402-118D7	157.18	28.98	15.03	31.22	1.45	2.10	1.23	1.52	1.59
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	20.25	6.75	4.05	0.00	1.35	2.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	17.49	31.77	6.65	2.71	1.48	1.23	1.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	15.90	17.08	3.24	2.65	0.59	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	24.20	10.37	0.00	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.32	17.67	6.82	3.10	2.79	1.24	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	17.42	13.90	1.87	3.11	0.21	1.87	1.04	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	20.84	2.32	0.00	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	41.79	26.03	5.76	5.51	1.75	2.00	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	18.62	18.15	4.19	2.79	0.00	4.19	1.40	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	38.93	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	59.75	27.43	5.69	5.08	0.81	2.03	1.42	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	41.58	18.21	3.96	2.77	1.58	2.77	3.17	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	17.10	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	127.43	24.78	8.85	15.93	2.65	0.88	1.77	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	62.31	13.30	6.46	15.20	0.76	1.52	0.76	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	76.32	22.37	6.58	0.00	1.32	1.32	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	220.71	22.92	8.28	20.80	2.33	1.06	0.64	1.06	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	52.49	16.57	1.84	0.92	0.92	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	308.79	35.47	10.73	25.63	2.38	2.98	1.79	2.68	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	35.21	6.71	5.03	1.68	0.00	0.00	3.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	263.70	27.60	11.29	42.15	1.51	2.01	3.01	3.76	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	80.81	13.78	5.47	7.84	0.95	2.14	1.90	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	96.20	9.95	2.21	2.76	2.21	1.66	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	285.50	22.33	10.59	46.51	1.61	0.92	0.46	2.53	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	111.27	16.20	6.10	8.20	1.05	1.89	0.84	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	263.35	26.91	8.15	12.23	1.02	2.04	1.43	0.20	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	191.80	22.53	10.08	33.90	1.93	1.50	1.07	1.50	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	121.15	14.23	4.45	4.67	0.44	1.33	0.89	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	72.23	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	260.19	22.78	11.83	20.81	1.53	1.75	0.66	0.66	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	104.94	17.74	3.55	2.03	0.51	1.52	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	71.25	14.91	4.97	0.00	0.00	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	236.46	23.10	10.87	19.84	0.54	1.90	0.27	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	130.28	17.06	2.65	6.47	1.47	2.65	1.47	0.88	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	76.32	16.35	0.00	0.00	2.18	3.27	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	224.42	24.99	9.13	49.50	0.48	0.96	0.96	3.36	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	136.88	19.61	5.20	16.41	0.80	0.40	0.00	1.20	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	85.02	27.42	8.23	8.23	0.00	1.37	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	188.72	23.53	5.51	39.05	1.00	1.50	1.50	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	80.84	0.00	53.89	26.95	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	61.16	14.27	2.04	0.00	0.00	2.04	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	143.64	29.34	8.32	19.27	0.88	1.75	0.44	0.88	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	89.40	25.38	1.10	3.31	0.00	1.10	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	79.41	34.58	12.17	0.64	1.92	1.28	3.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	153.46	33.22	12.89	22.56	0.74	2.48	0.25	0.99	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	81.42	14.61	4.87	5.57	3.48	2.78	2.09	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	70.72	64.09	22.10	4.42	0.00	6.63	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	137.09	70.77	22.56	44.44	7.18	3.42	2.05	0.68	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	91.02	20.57	8.31	1.75	1.31	1.31	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	56.11	51.49	11.72	4.26	1.78	3.20	2.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	115.31	60.32	19.08	22.72	3.65	3.93	0.56	1.40	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	96.43	24.94	9.56	4.16	3.33	1.66	2.08	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	57.69	60.02	9.91	1.75	0.58	3.50	3.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	126.10	75.11	25.34	17.80	5.73	3.92	1.51	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	113.95	40.49	11.27	13.36	1.67	2.92	2.92	1.25	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	86.63	0.00	0.00	7.22	0.00	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	100.67	60.03	16.62	6.46	10.16	3.69	6.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	85.94	40.41	10.24	4.55	6.83	2.28	3.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	61.08	66.88	11.33	4.84	3.73	4.56	4.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	80.08	85.26	17.62	20.73	6.74	2.59	2.33	0.52	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	95.66	57.48	11.58	3.00	1.29	2.57	5.15	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	53.36	80.03	10.16	0.64	4.45	8.26	4.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	76.86	93.41	14.68	3.74	5.60	6.41	4.54	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	95.79	75.43	16.76	9.58	3.89	5.09	6.29	0.90	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	44.21	78.25	13.14	4.10	3.67	5.23	8.76	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	61.47	97.78	18.16	27.71	7.01	7.01	4.14	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	84.47	57.05	9.07	7.08	2.87	4.20	3.10	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	60.29	100.87	10.62	0.76	6.83	7.58	6.07	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	68.47	96.88	17.05	28.13	6.53	4.26	2.84	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	97.83	73.25	14.26	15.49	4.18	3.93	5.65	0.98	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	51.48	128.38	14.34	4.56	3.26	6.52	10.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	70.57	126.14	20.88	13.23	9.11	2.94	5.88	1.18	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	83.33	81.02	14.42	6.63	4.61	5.77	6.34	1.15	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	86.96	124.06	13.60	13.19	7.83	3.71	11.54	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	65.51	136.68	13.70	7.44	7.15	4.17	7.15	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	7.53	7.53	26.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	12.48	3.56	10.69	0.00	3.56	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	39.10	50.93	15.77	32.86	5.59	3.61	1.64	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	28.40	8.42	18.94	1.05	3.16	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	25.11	21.75	9.49	31.23	0.79	3.95	0.79	0.59	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	24.21	27.94	16.76	9.31	0.93	3.73	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	31.92	27.79	13.52	15.02	1.13	1.13	1.88	1.50	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.11	17.31	7.72	5.06	0.53	2.66	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	23.64	29.29	10.18	19.57	1.58	2.38	1.13	0.45	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	33.15	33.89	11.05	22.10	0.74	5.16	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	37.74	45.07	13.56	21.99	1.83	0.73	2.56	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	34.22	26.45	15.56	18.67	0.00	0.00	0.00	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	39.55	22.45	10.15	17.64	0.53	2.14	2.67	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	73.41	15.46	11.59	65.69	3.86	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	62.62	56.56	15.15	30.30	5.05	7.07	2.02	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	38.79	24.88	8.85	10.12	2.95	2.95	1.26	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	44.94	13.62	6.81	8.17	2.72	1.36	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	36.88	8.27	3.81	5.72	0.64	1.91	0.00	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	33.20	6.48	5.67	4.86	0.81	2.43	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	33.23	7.55	1.51	4.53	0.00	3.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	205.57	34.26	22.84	11.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	75.04	9.79	6.52	3.26	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	109.31	28.51	9.50	0.00	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	213.33	37.65	25.10	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	47.83	12.71	13.36	5.60	1.51	0.86	0.65	1.08	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	33.45	8.88	14.63	5.23	1.57	1.05	0.52	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	44.05	24.03	12.68	32.71	0.67	2.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	25.46	25.88	19.20	1.67	0.00	2.92	1.25	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	22.25	11.41	19.20	7.61	1.33	1.14	0.57	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	44.68	28.73	6.38	6.38	3.19	1.60	4.79	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	44.20	20.40	10.20	4.76	1.36	2.72	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	7.35	5.51	12.86	0.00	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	54.41	27.20	16.74	23.86	0.42	2.09	1.67	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	28.36	22.08	14.88	2.32	1.63	0.93	1.39	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	107.28	34.05	25.40	6.49	1.35	1.08	2.43	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	59.50	28.59	16.19	12.40	1.05	1.47	2.10	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00	222.69	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	78.92	15.39	11.91	6.45	0.00	0.99	1.99	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	29.77	20.84	18.95	28.15	0.81	0.27	2.44	1.08	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	46.24	16.77	16.55	1.36	1.36	1.13	1.59	0.91	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	118.56	28.58	28.74	5.06	2.29	0.98	1.14	0.49	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	71.26	24.79	16.40	15.86	2.37	0.55	1.09	0.55	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	102.37	36.07	22.28	7.43	1.06	2.12	0.53	1.06	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	114.06	24.01	18.61	9.00	0.60	1.20	3.60	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	22.97	11.81	12.14	50.54	0.33	0.00	0.00	2.30	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	67.49	24.23	21.79	2.11	2.11	1.30	1.30	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	72.85	27.34	15.87	8.82	1.41	0.35	3.00	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	87.90	29.54	18.28	6.33	2.81	1.41	0.70	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	88.72	23.45	26.66	11.49	3.68	0.92	1.84	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	171.28	26.67	26.35	40.17	2.89	1.93	1.93	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	23.11	10.00	12.42	10.00	0.00	0.34	1.72	6.21	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	10.11	15.17	63.21	0.00	0.00	0.00	5.06	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	85.55	21.39	14.04	7.35	1.56	0.45	2.01	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	85.53	24.13	21.17	7.20	0.85	1.27	3.39	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	45.10	16.61	14.95	8.54	0.95	0.71	2.37	2.14	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	203.03	25.33	31.34	48.51	0.00	2.15	0.00	0.86	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	18.06	99.31	0.00	0.00	0.00	45.14	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	188.60	36.99	24.66	6.00	1.33	0.33	2.33	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	121.28	26.60	16.23	8.12	0.45	0.45	1.80	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	98.41	21.03	15.08	5.16	1.98	0.79	0.79	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	163.44	27.86	20.43	10.22	0.00	0.00	3.71	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	82.86	20.43	29.89	36.70	0.76	1.14	0.38	1.51	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	145.02	23.14	20.53	3.26	0.98	1.63	0.33	1.30	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	191.31	29.20	27.89	5.67	2.61	3.92	5.67	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	124.83	23.07	15.38	9.50	2.26	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	138.46	16.76	20.28	10.58	0.00	2.65	0.88	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	154.24	22.60	21.28	5.32	2.66	0.66	0.66	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	250.01	27.78	20.34	52.08	1.49	0.99	2.98	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	154.66	19.14	23.74	3.45	1.15	0.38	2.68	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	124.91	33.27	42.64	30.85	0.91	0.60	1.21	1.81	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	122.23	14.37	13.92	16.36	0.22	0.88	0.88	0.66	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	126.72	28.46	17.62	13.55	1.36	2.03	3.39	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	51.10	5.11	5.11	91.97	0.00	0.00	0.00	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	239.60	24.39	32.92	61.58	1.22	0.61	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	130.93	22.66	22.35	7.55	0.63	0.94	1.26	1.26	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	181.59	22.70	36.32	12.71	1.82	1.21	1.82	0.91	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	184.34	22.15	18.99	59.34	1.58	2.37	0.79	2.37	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	24.94	13.60	7.94	27.21	1.13	1.13	1.13	10.20	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	10.12	136.56	0.00	0.00	0.00	5.06	5.06
Myoblast, donor1	11241-116D8	89.82	21.49	14.04	16.65	1.74	2.24	0.50	0.99	0.25
Myoblast, donor2	11322-117D8	50.44	12.47	12.66	15.34	0.77	0.58	1.34	0.58	0.38
Myoblast, donor3	11398-118D3	152.69	24.55	19.84	20.18	1.85	1.51	2.69	0.67	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	3.36	16.64	5.69	5.98	0.15	2.04	0.73	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	46.13	139.92	56.89	18.14	11.38	11.07	2.15	1.85	0.62
Natural Killer Cells, donor2	11311-117C6	27.74	139.02	52.77	13.87	4.82	9.05	2.41	1.81	0.00
Natural Killer Cells, donor3	11387-118C1	34.42	153.87	54.30	13.25	6.07	10.12	2.02	1.29	0.92
Neural stem cells, donor1	11275-116H6	6.17	13.79	9.07	0.36	0.36	0.36	0.36	0.00	1.81
Neural stem cells, donor2	11352-117H2	1.93	7.70	5.78	1.93	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	10.24	5.69	3.41	1.14	0.00	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	2.42	7.27	1.98	2.64	0.44	0.22	0.22	0.00	0.22
Neurons, donor3	11655-122E8	4.93	1.64	1.64	1.64	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	56.61	239.43	89.09	13.92	8.35	20.42	8.35	6.50	5.57
Neutrophils, donor2	11314-117C9	28.99	229.01	66.67	28.99	11.60	17.39	2.90	14.49	17.39
Neutrophils, donor3	11390-118C4	106.29	427.59	109.34	4.89	14.66	18.94	7.33	8.55	16.49
Nucleus Pulposus Cell, donor1	11252-116F1	68.87	28.02	26.83	15.32	1.19	0.83	1.54	0.71	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	41.03	18.23	15.30	19.86	0.00	0.33	1.30	0.98	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	29.88	17.65	9.23	8.82	0.20	0.40	0.80	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	86.03	14.45	22.99	41.02	2.62	3.30	0.69	0.96	0.83
Olfactory epithelial cells, donor2	11934-125I8	142.57	9.99	19.25	22.29	2.17	0.87	1.01	5.65	0.72
Olfactory epithelial cells, donor3	11935-125I9	131.33	8.63	17.37	16.80	2.27	0.79	0.45	0.91	0.23
Olfactory epithelial cells, donor4	11936-126A1	141.42	13.93	19.77	17.04	2.63	0.68	1.07	0.58	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	103.51	40.32	16.25	19.26	1.20	1.20	4.21	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	122.30	18.93	22.33	18.93	0.85	1.06	0.85	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	97.16	18.29	16.00	11.43	0.00	0.00	1.14	0.00	4.57
Osteoblast - differentiated, donor3	11425-118G3	34.14	4.34	11.17	3.72	0.62	0.62	0.00	1.24	1.24
Osteoblast, donor1	11277-116H8	54.53	14.46	16.42	23.45	0.59	0.20	0.59	0.59	0.20
Osteoblast, donor2	11354-117H4	59.70	18.96	23.88	2.81	0.70	2.11	1.40	0.70	0.00
Osteoblast, donor3	11426-118G4	61.85	24.53	18.48	5.87	1.24	0.89	0.53	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	20.38	9.27	11.20	3.96	0.76	1.35	0.25	1.26	1.10
Pericytes, donor1	11491-119E6	20.14	22.14	11.02	4.34	0.56	0.33	1.45	0.89	0.56
Pericytes, donor2	11571-120E5	9.51	14.49	7.02	4.75	0.23	0.68	0.45	0.00	0.00
Pericytes, donor3	11652-122E5	75.89	41.50	33.98	27.26	2.03	2.44	1.42	1.22	0.41
Perineurial Cells, donor1	11499-119F5	13.11	17.74	12.77	5.54	0.90	0.11	0.79	0.11	0.00
Perineurial Cells, donor2	11579-120F4	116.67	16.84	26.59	8.93	1.38	1.75	0.37	0.46	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	36.66	126.54	45.26	25.18	7.01	9.24	3.51	0.64	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	42.12	92.56	52.65	11.02	4.16	3.67	3.43	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	47.11	116.09	58.37	4.01	4.14	6.34	1.81	1.29	0.13
Placental Epithelial Cells, donor1	11278-116H9	24.39	20.81	10.76	5.50	2.87	1.43	1.43	0.00	1.43
Placental Epithelial Cells, donor2	11355-117H5	33.27	17.74	7.76	16.63	3.33	2.22	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	28.66	32.79	21.99	12.56	6.48	4.32	1.96	0.79	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	190.82	18.04	16.14	23.10	1.90	0.95	1.27	10.76	0.95
Preadipocyte - breast, donor1	11467-119B9	246.11	19.88	21.20	46.33	1.69	0.38	1.13	3.19	4.31
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	143.32	16.32	25.45	12.92	0.52	0.52	0.65	0.13	0.52
Preadipocyte - breast, donor2	11328-117E5	166.84	15.76	19.14	29.72	1.13	1.35	1.58	1.80	0.90
Preadipocyte - omental, donor1	11468-119C1	180.72	18.54	17.80	19.07	0.75	0.85	0.85	3.73	5.22
Preadipocyte - omental, donor2	11329-117E6	224.35	27.06	22.70	21.39	2.18	2.62	1.75	3.06	3.06
Preadipocyte - omental, donor3	11403-118D8	210.43	23.21	20.34	49.42	2.29	1.29	2.86	4.01	1.72
Preadipocyte - perirenal, donor1	11469-119C2	134.84	7.87	5.91	28.54	0.98	0.00	0.98	3.94	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	58.97	11.98	9.83	3.99	0.92	0.31	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	38.78	17.00	16.11	17.00	3.01	1.77	0.89	1.77	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	43.93	18.39	16.69	6.47	0.85	1.87	0.34	0.34	1.87
Preadipocyte - visceral, donor1	11280-116I2	40.43	21.33	18.35	5.59	1.68	1.21	0.93	0.47	1.30
Preadipocyte - visceral, donor2	11357-117H7	35.89	32.67	19.33	10.58	0.92	1.38	0.92	0.46	3.68
Preadipocyte - visceral, donor3	11429-118G7	26.65	14.21	9.93	12.02	0.52	0.63	0.84	0.63	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	46.76	43.29	19.91	11.16	4.98	3.02	2.41	3.32	5.13
Prostate Epithelial Cells, donor2	11331-117E8	86.94	37.10	20.31	27.90	5.55	4.47	2.17	3.52	5.55
Prostate Epithelial Cells, donor3	11404-118D9	29.95	43.42	12.80	9.31	6.49	4.16	1.65	1.53	3.00
Prostate Stromal Cells, donor1	11254-116F3	53.42	14.01	16.63	9.91	0.80	0.34	0.34	1.25	0.80
Prostate Stromal Cells, donor2	11332-117E9	33.53	19.90	14.34	9.86	0.54	1.08	1.61	1.08	0.36
Prostate Stromal Cells, donor3	11405-118E1	28.26	12.30	13.24	5.11	0.21	1.15	0.83	0.73	1.46
Renal Cortical Epithelial Cells, donor1	11516-119H4	28.83	38.32	12.77	9.12	3.65	5.84	1.82	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	9.36	32.99	6.79	11.02	1.94	3.33	1.59	0.49	0.35
Renal Epithelial Cells, donor1	11517-119H5	30.94	32.46	11.67	4.57	0.51	3.04	2.03	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	14.94	29.16	10.67	4.98	1.42	2.13	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	9.74	40.44	6.14	7.41	1.59	2.65	0.95	0.21	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	7.49	29.28	3.40	1.36	1.36	1.36	1.36	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	4.04	25.87	3.91	5.26	1.08	1.48	0.67	0.13	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	5.33	21.54	7.77	1.55	0.67	1.11	1.11	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	8.65	22.63	3.99	0.00	0.67	3.33	1.33	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	20.25	30.81	14.97	7.70	0.66	4.40	1.32	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	16.93	27.59	7.52	10.03	2.51	1.25	1.25	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	15.26	31.07	10.26	14.15	1.94	2.50	1.66	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	33.02	49.66	14.76	9.39	5.64	4.03	1.07	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	18.55	24.04	13.07	7.59	4.64	2.11	0.42	0.84	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	22.95	35.87	11.76	8.68	3.66	4.24	1.16	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	6.48	14.78	4.15	4.15	1.30	1.04	1.56	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	19.90	36.10	12.51	6.82	0.57	1.42	1.71	1.14	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	14.41	30.87	6.17	6.17	1.03	0.00	3.09	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.08	28.60	10.04	6.77	1.25	2.26	1.25	0.75	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	82.59	43.03	19.38	19.38	5.75	3.47	1.47	1.07	2.14
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	10.72	12.51	10.72	0.89	0.89	0.00	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	3.85	6.05	3.85	4.40	1.10	0.00	1.10	0.55	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	3.48	5.22	4.06	0.58	0.00	0.00	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	5.98	17.03	4.68	4.16	1.30	0.39	0.26	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	8.24	20.66	7.65	4.37	1.59	1.29	0.70	0.10	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	8.92	21.30	5.91	4.80	0.78	0.78	0.67	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	9.55	15.63	6.95	6.08	1.36	0.37	0.74	0.74	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	7.34	22.26	6.18	4.78	0.70	1.52	0.82	0.93	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	10.63	19.18	7.63	3.00	0.92	1.39	0.92	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	7.39	18.76	6.30	2.05	1.37	0.55	0.82	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	9.08	15.43	7.87	4.39	1.36	1.21	1.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	8.42	19.89	9.14	5.02	0.72	1.25	0.72	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.03	23.53	6.03	2.30	1.43	0.43	0.86	0.29	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	7.40	18.46	6.01	4.72	2.15	0.43	0.75	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	6.86	23.01	7.52	3.10	1.99	1.77	0.44	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	8.03	20.07	7.07	1.53	2.87	0.76	0.38	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	8.29	21.05	6.89	2.79	1.21	0.28	0.93	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	9.40	21.05	5.07	4.32	1.32	0.00	0.75	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	8.23	19.77	5.71	2.26	1.59	0.27	1.06	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	7.20	20.73	7.40	1.85	0.68	0.68	1.17	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	3.63	20.05	5.35	2.10	1.72	0.57	0.76	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	7.69	21.89	4.59	1.60	1.39	0.53	0.75	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	8.97	16.26	8.13	3.36	0.84	0.84	1.68	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	6.15	21.19	6.84	3.59	0.68	0.85	1.03	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	8.75	21.15	4.19	2.01	1.46	0.73	1.64	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	8.46	22.07	8.09	3.68	1.35	1.10	0.74	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	6.72	16.52	5.24	2.28	1.61	0.27	0.67	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	10.61	18.16	5.43	6.60	0.71	0.24	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	8.33	25.99	9.72	3.97	1.59	0.79	0.40	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	7.48	25.26	5.61	4.68	1.64	0.47	1.17	0.47	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	10.99	17.63	8.71	4.35	0.83	0.62	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	8.85	23.89	7.52	3.10	0.66	0.22	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	7.10	22.35	3.97	2.72	1.88	0.21	0.42	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	11.17	20.46	7.27	3.90	1.21	0.27	0.13	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	8.86	20.09	5.79	1.02	1.53	1.19	2.04	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	9.25	16.77	7.71	2.51	0.96	0.96	0.96	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	10.49	15.47	6.36	4.30	0.86	0.34	0.52	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	8.64	22.50	8.50	1.51	1.10	0.82	1.37	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	9.03	18.39	5.42	3.28	0.66	0.66	0.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	6.82	20.11	4.09	1.70	1.87	0.51	1.36	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	6.51	17.31	6.36	3.26	0.89	0.44	0.89	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	7.73	23.46	6.40	2.40	0.27	0.00	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	7.19	19.08	6.36	2.21	2.90	0.14	0.41	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	6.19	12.86	5.24	4.52	0.71	0.71	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	8.06	25.39	7.46	1.61	2.62	1.01	1.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	7.25	13.37	7.06	3.48	1.13	0.47	0.38	0.38	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	7.69	12.93	9.08	4.54	1.40	1.05	0.70	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	11.18	11.79	8.46	2.72	0.60	0.30	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	6.98	9.18	4.90	3.55	1.84	0.12	0.12	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	13.39	16.16	11.35	4.66	1.31	0.73	0.29	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	10.95	15.82	10.34	2.43	0.61	1.22	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	8.44	8.74	5.12	3.32	0.00	0.30	0.00	0.90	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	18.10	27.14	12.89	7.46	0.90	1.13	0.23	1.81	4.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	12.58	12.88	10.18	4.19	1.50	0.60	0.30	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	13.93	16.06	11.22	5.08	1.18	0.71	0.47	3.07	3.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	13.45	15.37	11.53	5.34	0.85	1.28	0.21	2.56	2.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	10.22	14.42	11.42	5.41	0.60	1.20	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	33.85	36.86	14.67	7.90	1.69	0.75	2.26	1.13	0.00
Schwann Cells, donor2	11578-120F3	17.01	10.21	6.80	10.21	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	20.37	17.75	12.27	9.20	0.66	1.53	0.88	0.88	0.00
Sebocyte, donor1	11220-116B5	159.40	84.90	45.46	13.69	15.34	6.57	4.38	0.55	6.57
Sebocyte, donor2	11301-117B5	79.04	33.55	14.25	12.41	4.14	3.68	2.30	0.46	1.38
Sebocyte, donor3	11378-118B1	85.12	28.03	15.25	13.81	3.92	2.68	2.68	0.82	1.03
Sertoli Cells, donor1	11255-116F4	132.53	21.54	29.82	14.91	0.00	4.97	1.66	3.31	4.97
Sertoli Cells, donor2	11333-117F1	121.45	28.24	22.59	56.49	0.00	0.00	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	60.26	41.26	23.84	38.89	0.79	1.41	2.20	1.32	3.52
Skeletal Muscle Cells, donor2	11358-117H8	13.01	6.51	10.84	2.17	0.00	1.45	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	21.74	27.59	16.72	6.69	0.84	0.84	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	17.28	10.37	9.58	6.60	0.31	1.10	0.00	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	22.15	11.74	11.59	11.45	0.45	1.19	0.89	0.00	0.15
Skeletal Muscle Cells, donor6	11459-119B1	18.62	15.39	11.70	7.39	0.46	1.23	0.77	0.77	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	54.18	19.78	23.44	28.10	0.63	0.38	0.76	0.88	1.51
Skeletal Muscle Satellite Cells, donor2	11321-117D7	34.96	24.26	13.98	8.13	0.71	2.57	1.00	0.86	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	23.31	15.28	14.09	6.05	0.79	1.29	0.20	0.30	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	89.64	28.73	23.59	37.74	1.52	1.52	1.18	0.67	1.94
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.09	24.61	13.03	7.96	0.72	0.72	2.17	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	23.94	9.22	11.83	10.73	0.69	0.69	0.96	0.41	0.14
Skin - palm, donor1	10286-104F7	13.43	37.61	13.43	5.37	2.69	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	162.61	34.02	23.35	18.16	4.32	4.18	1.15	2.31	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	51.53	24.54	21.27	9.81	2.45	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	116.33	26.74	17.66	7.66	4.93	4.93	1.30	0.65	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	121.91	27.25	22.94	27.52	4.59	5.42	0.97	2.64	7.78
Small Airway Epithelial Cells, donor2	11334-117F2	129.83	35.59	29.12	20.96	3.94	4.92	0.70	1.27	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	155.41	32.56	31.08	21.36	2.33	2.11	1.48	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	102.01	41.15	27.13	10.79	4.35	3.90	1.87	1.12	1.12
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	29.93	16.35	1.85	11.42	1.85	0.93	0.62	0.62	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	292.37	53.36	57.14	31.35	4.22	0.89	2.00	3.11	4.45
Smooth Muscle Cells - Aortic, donor0	11210-116A4	82.30	24.10	15.28	17.05	2.94	6.47	2.94	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	180.55	35.58	29.39	21.66	2.65	1.99	2.21	1.10	2.21
Smooth Muscle Cells - Aortic, donor2	11360-117I1	110.65	24.41	19.30	28.75	2.76	4.33	1.58	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	139.83	38.63	22.40	13.91	2.32	3.86	0.77	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	30.02	4.00	9.01	3.00	0.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	139.60	26.22	23.29	20.89	2.26	1.46	1.73	0.53	1.60
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	98.86	27.93	21.94	22.39	1.77	1.55	1.99	3.10	1.99
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	182.96	17.92	17.67	6.02	1.41	1.66	1.28	0.38	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	4.88	14.33	3.58	6.19	1.30	0.65	1.30	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	37.80	31.60	17.13	6.50	0.30	3.25	1.18	0.59	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	38.87	31.04	15.52	3.99	2.14	1.57	1.71	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	35.30	19.52	15.29	7.97	0.81	1.63	1.79	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	33.18	20.40	28.01	7.00	1.52	0.30	0.61	1.22	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	43.95	22.23	15.41	8.08	0.51	2.02	0.76	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	226.47	42.84	6.12	18.36	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	84.40	13.83	15.26	7.63	0.48	0.95	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.98	16.37	8.55	7.23	0.44	1.18	1.62	0.74	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	21.52	14.85	13.56	7.53	1.08	0.86	1.51	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	18.47	15.74	11.97	6.93	0.84	1.68	1.47	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	111.21	29.70	20.11	37.12	2.17	2.47	1.39	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	178.93	45.27	22.64	34.49	3.23	1.08	0.00	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	115.36	46.92	15.54	16.44	3.29	2.09	1.79	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	17.41	18.44	7.51	5.80	1.02	0.68	0.68	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	39.03	21.36	15.31	11.15	1.02	1.10	0.94	0.16	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	105.87	48.91	18.62	16.20	3.82	2.52	3.52	5.23	10.57
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	261.23	52.34	30.72	85.33	3.87	3.41	2.05	5.46	3.41
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	209.52	25.36	20.53	31.40	0.60	0.60	1.81	1.21	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	12.45	16.96	11.13	3.71	0.53	0.79	0.79	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	25.43	14.65	10.92	17.58	1.07	0.67	0.53	0.40	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	50.84	25.54	18.03	16.65	1.00	0.75	0.38	1.25	2.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	30.44	18.26	9.89	4.57	0.76	1.52	0.25	0.25	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	73.12	22.47	21.71	21.56	1.21	1.66	0.75	0.75	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	75.77	27.01	16.50	20.25	1.50	0.75	0.00	0.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	27.14	21.97	15.51	0.00	2.58	0.00	2.58	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	156.73	23.25	26.51	4.65	2.33	2.33	0.93	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	241.33	45.44	18.68	33.32	2.02	2.02	2.52	3.53	5.55
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	165.47	32.91	20.06	22.56	3.76	1.88	1.88	0.31	2.51
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	18.88	22.42	9.73	3.54	0.59	0.88	0.59	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	25.58	15.83	10.91	2.83	1.08	0.75	1.00	0.25	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	15.42	15.88	7.47	5.61	0.00	1.40	1.40	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	33.39	35.12	13.53	5.61	1.58	2.88	0.86	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	41.81	29.83	14.28	15.81	2.29	2.55	1.78	0.51	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	32.91	19.93	18.43	13.54	1.50	1.69	0.38	0.38	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	15.65	28.37	9.92	5.45	0.98	1.82	1.12	0.28	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	46.25	43.15	23.80	13.24	1.76	3.02	2.35	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	9.52	21.43	4.29	3.33	0.95	0.48	2.86	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	28.38	27.89	12.97	4.65	1.47	1.96	1.22	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	73.35	21.87	13.70	19.44	1.10	0.88	1.55	1.55	2.65
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.66	9.07	9.95	4.68	0.00	0.59	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	57.92	26.24	21.38	5.44	1.36	0.39	0.97	1.36	1.36
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	34.91	18.78	11.37	6.88	1.85	1.06	0.79	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	4.09	8.18	3.72	10.41	1.12	0.00	0.00	0.74	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	10.06	16.53	9.34	8.98	1.44	0.00	0.36	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.83	15.90	4.83	0.85	1.99	1.42	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	11.03	6.30	8.67	20.88	1.58	0.39	0.00	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	23.11	12.70	10.16	7.62	1.52	1.02	0.51	2.54	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	28.35	33.94	23.96	11.98	1.20	2.80	1.60	1.60	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	33.02	8.78	10.87	8.78	0.84	0.42	1.25	2.09	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	18.79	7.79	11.92	15.13	0.00	0.46	1.38	0.46	0.00
Synoviocyte, donor1	11291-117A4	98.64	17.00	15.65	12.96	1.68	0.67	1.01	1.51	1.68
Synoviocyte, donor2	11368-117I9	122.70	13.58	24.31	21.46	1.01	0.50	1.34	1.68	1.84
Synoviocyte, donor3	11440-118H9	104.11	12.29	13.85	31.95	0.22	0.22	1.12	1.79	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	21.08	20.37	12.51	7.15	2.14	1.07	1.07	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	45.59	13.87	13.87	11.89	0.00	0.00	0.00	1.98	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	12.97	15.75	12.50	5.56	1.16	0.69	0.69	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	59.57	25.23	17.99	63.51	4.01	2.87	1.15	0.14	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	41.36	13.14	10.44	8.50	1.16	0.39	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	49.25	22.33	20.04	13.74	4.01	3.44	0.57	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	79.47	41.58	21.90	22.27	5.41	4.06	1.48	1.11	2.09
Urethra, donor2	10319-105A4	39.57	41.36	23.38	5.40	1.80	1.80	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	122.74	57.38	21.78	19.66	6.11	8.24	2.66	0.00	1.06
Urothelial Cells, donor2	11600-120H7	54.88	28.44	18.03	36.85	4.01	5.21	1.60	0.40	0.40
Urothelial Cells, donor3	11681-122H7	70.37	32.55	24.75	23.15	3.44	6.19	1.38	0.92	0.23
Urothelial cells, donor0	11216-116B1	89.16	51.93	38.34	33.43	5.35	7.58	2.01	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	2.67	103.21	8.90	7.12	3.56	2.67	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	7.15	112.94	8.58	12.87	5.72	8.58	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	10.27	62.29	10.27	8.90	3.42	4.11	2.74	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	6.89	80.23	7.58	7.92	3.44	5.85	0.69	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	6.97	83.09	6.97	4.65	1.16	2.32	1.74	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	7.29	104.12	8.33	10.41	6.25	4.16	2.08	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	8.26	85.35	13.77	7.34	2.75	3.67	0.92	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	4.56	77.60	4.56	13.69	0.91	2.74	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	7.65	26.65	6.41	6.41	1.11	2.47	1.23	0.49	0.49
Wilms' tumor cell line:HFWT	10597-108E3	1.76	28.16	6.16	0.88	0.00	0.88	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	13.69	25.70	14.52	11.45	3.91	2.51	1.12	0.28	0.00
achilles tendon, donor2	10292-104G4	12.40	20.67	12.40	8.27	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	9.43	31.36	8.16	4.08	1.78	2.80	1.53	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	100.07	83.12	19.97	22.99	5.57	2.55	3.71	0.70	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	4.87	33.12	7.83	3.80	2.85	2.14	1.42	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	1.09	20.68	0.82	0.54	0.54	0.27	1.90	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1.12	14.90	1.97	4.50	0.56	1.41	0.56	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	2.33	21.78	4.23	2.96	0.63	0.63	0.42	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	2.18	18.51	2.99	5.17	0.27	0.54	0.27	0.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1.76	15.42	4.41	1.76	0.88	0.00	0.44	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	4.90	18.78	10.21	4.49	2.45	1.63	0.82	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	6.99	18.25	4.66	3.11	1.16	2.72	1.55	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1.47	10.49	1.66	1.47	0.37	0.55	0.74	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3.90	11.70	7.80	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	5.34	12.78	6.04	3.25	0.23	0.93	0.70	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	2.85	21.49	3.62	5.18	0.78	0.78	0.52	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1.17	16.95	3.51	5.26	1.17	1.46	0.00	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	5.11	24.63	8.37	2.32	0.93	1.86	1.39	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	6.17	23.44	5.35	2.06	0.41	2.47	0.82	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	8.29	52.18	18.11	1.84	2.46	3.07	2.76	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	4.27	29.02	9.39	1.71	2.13	2.13	0.85	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	4.55	30.63	7.58	2.12	1.52	3.34	2.43	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	7.70	29.37	8.42	1.44	2.65	2.17	2.41	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1.34	8.24	1.11	1.11	0.45	0.67	0.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	3.00	15.34	3.67	1.00	0.00	1.33	0.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	3.72	9.29	5.57	0.00	0.00	0.00	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	4.90	12.43	5.27	3.77	0.00	1.13	0.38	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.87	20.06	5.23	0.87	0.87	0.87	1.31	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	7.50	15.00	9.37	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	11.54	13.89	8.24	0.47	1.41	2.59	0.24	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	45.45	25.44	16.60	5.58	1.24	1.71	1.24	0.78	2.17
adipose, donor1	10184-103D4	0.00	4.69	2.93	21.70	0.00	0.59	0.00	0.59	2.35
adipose, donor2	10185-103D5	0.81	22.30	3.24	21.09	0.00	0.41	2.43	0.41	0.00
adipose, donor3	10186-103D6	3.00	23.96	4.36	10.89	0.82	0.27	0.00	0.54	0.82
adipose, donor4	10187-103D7	18.20	11.27	4.33	5.20	0.87	0.00	0.87	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	0.32	29.99	1.42	3.00	0.63	0.32	3.95	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	61.84	43.65	3.64	3.64	0.00	10.91	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	5.34	29.35	9.21	4.67	1.20	2.27	2.00	0.00	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	6.07	27.15	5.72	5.00	1.43	2.50	1.07	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	46.83	36.40	24.81	18.55	8.11	3.48	1.85	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	60.18	28.74	18.60	9.80	5.07	3.04	3.04	1.35	1.35
amniotic membrane cells, donor3	12237-129G5	14.44	30.93	15.61	6.78	5.30	2.36	5.30	0.59	0.00
amygdala - adult, donor10196	10167-103B5	7.11	4.74	2.37	1.19	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	4.06	10.95	2.03	0.20	0.20	0.20	0.41	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	3.55	3.87	1.29	1.29	0.32	0.97	0.32	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	76.53	53.22	23.17	12.61	3.82	2.80	3.82	1.78	3.31
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	4.41	67.07	5.96	11.69	3.09	3.97	1.54	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	0.33	8.02	0.33	1.00	0.00	0.33	0.67	0.00	0.00
aorta, adult, pool1	10052-101G7	44.33	31.58	22.56	5.49	1.77	0.98	0.59	0.20	0.00
appendix, adult	10189-103D9	31.05	40.36	12.42	6.21	1.94	2.72	2.72	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.34	13.76	1.03	5.50	1.03	0.34	0.34	0.00	0.34
artery, adult	10190-103E1	14.95	12.23	4.08	4.08	2.72	0.00	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	6.08	22.16	5.36	3.91	1.45	1.59	0.72	0.14	0.00
b cell line:RPMI1788	10427-106D4	14.28	49.07	8.77	3.72	2.68	4.46	3.12	0.00	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	76.02	18.31	18.87	20.25	1.66	2.77	0.55	1.39	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	20.94	29.67	10.82	9.33	1.69	1.39	1.29	0.10	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	66.62	59.08	11.55	29.79	4.69	3.51	1.67	1.17	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.00	14.54	2.80	3.36	0.56	0.56	1.68	0.00	0.00
bladder, adult, pool1	10011-101C2	26.07	31.61	14.45	4.35	1.30	1.20	1.74	0.65	1.20
blood, adult, pool1	10053-101G8	13.29	110.73	15.50	8.86	0.00	4.43	6.64	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	77.93	17.13	15.41	9.42	1.71	0.86	1.71	0.00	0.00
bone marrow, adult	10192-103E3	57.36	24.97	14.85	8.77	2.70	1.35	2.70	2.02	0.00
brain, adult, donor1	10084-102B3	3.08	7.18	1.03	1.03	0.00	0.00	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	3.56	5.12	1.78	0.78	0.11	0.00	0.45	0.00	0.00
brain, fetal, pool1	10085-102B4	2.67	10.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	38.65	10.24	6.28	1.32	1.32	1.65	0.66	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	26.84	53.17	17.23	11.11	11.11	6.99	1.37	0.25	0.12
breast, adult, donor1	10080-102A8	42.30	23.36	10.10	3.16	2.53	0.63	3.79	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	29.85	20.58	9.02	6.99	1.65	2.67	0.76	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	39.58	53.19	27.21	8.97	3.09	6.18	3.09	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	0.23	7.60	1.61	6.45	0.23	0.23	0.92	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	64.39	30.74	18.64	7.26	7.02	3.87	1.94	0.73	0.48
carcinoid cell line:NCI-H1770	10703-109H1	0.00	11.75	0.94	4.70	0.47	0.00	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	9.52	42.44	7.11	1.64	1.64	1.64	1.09	0.11	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	2.22	19.01	2.85	5.07	0.95	0.32	0.95	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	11.18	11.18	7.45	1.33	0.53	0.27	0.27	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	5.76	9.21	8.06	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	1.34	8.03	1.67	0.33	0.00	0.50	0.00	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	1.53	3.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	2.93	6.59	1.46	0.37	0.00	0.37	0.73	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	5.83	8.74	0.00	5.83	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	1.71	25.83	2.35	1.07	1.28	0.21	0.64	0.00	0.00
cerebellum, adult, pool1	10083-102B2	1.38	13.11	2.07	0.69	0.69	0.69	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	2.49	10.79	3.32	0.83	0.00	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	6.56	5.55	4.29	1.26	0.00	0.00	0.50	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	21.20	15.35	5.85	5.12	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	119.05	89.00	36.38	17.83	21.14	5.90	2.59	2.16	1.15
cervical cancer cell line:ME-180	10553-107I4	137.05	30.16	42.42	11.43	6.30	4.97	0.66	0.83	0.50
cervix, adult, pool1	10013-101C4	45.25	33.49	14.59	14.49	1.47	0.73	1.26	0.73	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	115.37	29.40	23.13	38.46	2.23	1.11	0.56	0.70	1.67
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	37.88	20.90	2.61	2.61	1.31	3.92	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	128.13	76.43	53.81	22.12	23.24	21.13	2.11	6.96	11.18
choriocarcinoma cell line:SCH	10785-110H2	129.62	36.84	44.97	38.81	16.51	6.16	1.23	1.11	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	113.85	52.89	57.63	25.62	24.67	13.28	0.71	0.71	0.24
chorionic membrane cells, donor1	12238-129G6	77.50	15.96	21.65	15.39	3.13	2.85	0.57	0.57	0.85
chorionic membrane cells, donor2	12239-129G7	52.50	20.28	17.80	7.95	4.08	3.78	0.99	1.09	2.19
chorionic membrane cells, donor3	12240-129G8	67.59	20.88	23.08	17.58	5.49	7.14	1.65	4.40	3.85
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	3.03	2.02	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	2.88	15.56	5.38	4.23	0.77	2.31	0.77	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	8.45	12.04	9.93	1.27	0.63	0.63	0.63	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1.80	6.68	5.65	1.03	0.51	0.77	0.26	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2.90	9.19	4.84	0.97	0.48	0.73	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1.63	6.72	5.70	0.41	0.00	1.63	0.20	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	7.95	13.25	11.48	2.65	0.00	1.47	0.00	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	3.91	12.51	6.26	1.04	0.52	0.78	0.78	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	1.83	32.69	0.91	10.74	0.69	1.60	3.20	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	98.20	45.11	17.35	14.75	3.99	1.91	1.04	0.35	1.04
colon carcinoma cell line:CACO-2	10513-107D9	27.82	31.85	14.46	6.59	1.65	4.94	1.65	0.18	0.37
colon carcinoma cell line:COLO-320	10420-106C6	4.18	32.69	6.08	1.14	0.76	0.00	0.76	0.00	0.00
colon, adult, donor1	10082-102B1	30.94	28.56	15.47	14.28	0.00	3.57	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	21.86	32.55	12.10	10.93	1.65	2.70	1.06	0.47	0.24
colon, fetal, donor1	10070-101I7	20.39	53.15	15.45	21.01	1.85	1.24	3.71	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	18.33	41.25	0.00	0.00	9.17	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	72.66	19.97	25.92	11.47	1.70	3.40	0.00	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	70.33	15.24	19.62	14.49	0.30	4.08	0.45	0.15	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	78.12	12.41	22.42	16.64	0.85	5.78	0.00	0.14	0.28
corpus callosum, adult, pool1	10042-101F6	7.63	14.48	3.76	0.88	0.22	0.66	0.77	0.22	0.00
cruciate ligament, donor2	10295-104G7	32.42	22.69	13.78	5.67	1.62	0.81	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	19.26	25.68	16.85	5.62	4.01	0.00	1.61	0.00	0.00
diencephalon, adult	10193-103E4	2.16	6.00	1.68	1.20	0.96	0.00	0.00	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1.15	9.87	3.21	2.30	0.23	0.92	0.23	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	21.54	81.55	25.13	7.44	13.08	8.72	2.05	0.77	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	1.20	6.74	0.96	0.48	0.24	0.48	0.24	0.00	0.00
ductus deferens, adult	10196-103E7	44.35	33.39	12.96	6.48	1.00	2.99	2.49	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	15.84	60.49	17.28	4.32	1.44	1.44	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	11.03	33.10	9.56	8.83	1.47	0.00	3.68	0.00	0.00
dura mater, adult, donor1	10041-101F5	116.45	50.38	38.73	5.37	1.90	2.23	2.97	0.74	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	4.66	5.55	6.44	2.89	0.22	0.67	0.00	0.67	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	6.59	6.73	4.01	4.73	0.86	0.43	0.14	0.00	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	4.32	20.35	6.78	1.23	4.32	3.08	1.85	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	2.72	26.64	8.17	4.54	0.91	2.12	1.21	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	7.41	25.93	9.88	3.09	3.40	3.70	1.23	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	6.57	14.45	7.88	1.31	2.63	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	34.86	82.12	16.42	9.39	7.04	4.36	3.35	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	51.47	57.45	13.05	6.52	4.35	3.26	3.62	0.91	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	2.57	24.93	2.25	4.34	2.41	1.29	0.32	0.48	0.16
epidermoid carcinoma cell line:A431	10426-106D3	31.01	18.01	19.34	4.89	3.33	1.89	1.00	0.00	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	67.20	41.02	31.24	7.70	11.99	5.28	1.10	0.33	0.22
epididymis, adult	10197-103E8	54.00	32.86	17.37	11.93	3.56	2.72	2.09	1.26	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	55.00	33.89	24.84	13.48	1.60	1.06	1.95	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	13.37	9.04	3.93	2.36	0.00	1.97	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	205.49	20.05	26.21	17.56	3.28	1.70	0.13	2.10	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	237.68	30.90	43.01	14.07	5.02	2.66	1.08	1.57	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	195.04	21.73	25.77	14.45	3.14	2.24	1.01	1.57	0.11
esophagus, adult, pool1	10015-101C6	33.98	23.04	8.49	4.46	2.65	1.27	0.85	0.42	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	0.38	29.18	0.88	3.26	0.75	0.13	3.26	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	16.90	19.32	16.90	4.83	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	14.73	12.63	4.21	6.31	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	11.91	22.32	5.95	2.98	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	28.66	27.52	4.59	5.73	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	16.03	29.15	10.20	5.83	1.46	4.37	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	45.51	26.69	13.22	16.02	1.78	1.53	1.27	0.76	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	33.98	40.01	22.18	12.31	1.41	1.92	1.41	0.38	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	8.55	12.82	7.83	5.70	0.95	1.42	0.71	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	1.97	4.41	1.88	0.28	0.09	0.19	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	520.33	44.44	33.33	87.97	13.51	6.31	2.40	5.10	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	221.00	72.97	82.93	43.89	6.40	4.57	2.01	1.01	1.10
gall bladder, adult	10198-103E9	27.52	29.45	12.55	7.73	1.69	2.41	1.69	0.72	0.00
gamma delta positive T cells, donor1	11937-126A2	15.57	93.95	23.62	10.20	5.37	6.98	2.15	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	17.18	85.53	35.11	12.70	5.23	8.96	3.36	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	32.53	14.15	26.19	14.57	1.27	1.48	0.63	1.06	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	24.18	30.37	13.73	6.58	2.32	1.35	0.77	0.97	0.00
gastric cancer cell line:AZ521	10549-107H9	10.17	22.30	3.93	3.28	1.31	1.31	1.97	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	0.92	10.98	2.75	0.92	0.00	0.00	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	0.23	11.65	2.51	0.69	0.46	0.23	1.37	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	53.12	28.57	22.37	13.31	2.07	1.72	0.34	0.80	0.92
giant cell carcinoma cell line:Lu99B	10433-106E1	21.55	26.59	25.19	3.50	0.56	1.82	0.98	0.42	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	550.22	68.34	40.90	66.59	9.48	7.73	4.74	4.99	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	12.67	19.10	8.97	3.59	2.22	1.37	1.06	0.11	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	17.70	19.80	8.43	1.12	1.54	1.12	0.56	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	33.22	13.24	19.54	13.13	1.43	1.32	0.22	0.33	0.00
glioma cell line:GI-1	10413-106B8	26.94	21.67	16.40	5.27	1.46	1.17	0.88	0.59	0.88
globus pallidus - adult, donor10196	10175-103C4	1.46	8.02	5.83	2.92	0.00	0.00	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	5.37	14.16	1.22	1.22	0.49	1.22	0.24	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	1.37	9.58	0.00	4.11	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	2.66	5.86	1.07	2.66	0.00	0.53	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	115.02	29.37	0.00	2.45	7.34	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	21.86	0.00	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	15.68	0.00	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	34.88	25.92	20.80	10.88	1.60	2.88	0.32	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	4.13	6.43	5.51	0.00	1.38	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	5.03	7.77	3.66	1.83	1.83	1.37	0.46	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	4.51	7.09	8.37	0.64	1.93	1.29	0.64	0.64	0.00
hIPS, biol_rep1	14380-156B6	1.44	10.06	4.31	1.44	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	2.06	7.54	5.49	0.69	0.69	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	2.21	6.62	1.10	0.00	0.00	0.00	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	15.52	43.39	8.05	19.25	2.30	2.30	3.74	0.29	0.57
heart - mitral valve, adult	10205-103F7	84.01	26.61	10.76	17.04	1.79	0.00	1.49	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	23.53	16.21	9.15	6.80	1.83	0.00	0.52	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	208.16	14.15	14.99	24.15	0.83	0.83	2.50	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	68.97	51.83	22.65	22.24	16.73	4.08	1.43	1.84	0.20
heart, adult, diseased, donor1	10051-101G6	94.53	27.68	12.77	10.65	1.28	1.28	0.00	0.85	0.43
heart, adult, pool1	10016-101C7	60.71	27.14	9.89	11.27	1.15	0.69	0.46	0.00	0.00
heart, fetal, pool1	10046-101G1	38.92	36.66	13.45	5.03	1.03	1.64	3.18	0.31	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	154.88	31.47	25.92	22.21	2.16	3.70	1.54	0.93	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	23.78	9.51	1.19	1.19	4.76	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	9.50	44.09	6.30	4.53	2.10	1.88	1.66	0.11	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	9.47	36.53	6.80	3.64	1.09	2.06	1.21	0.61	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	10.61	45.47	7.38	4.35	1.21	1.62	1.72	0.20	0.10
hepatoma cell line:Li-7	10484-107A7	15.90	35.26	11.23	13.68	1.00	1.00	0.11	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	3.82	22.71	5.03	2.21	1.21	1.61	0.90	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	0.95	4.73	2.84	1.89	0.00	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	3.27	8.37	2.04	1.02	0.20	0.00	0.61	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	1.49	2.99	1.00	1.00	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	4.23	6.34	1.06	2.47	0.00	0.35	1.06	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	0.00	11.60	4.27	6.10	0.61	0.00	0.00	2.44	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	0.39	17.67	1.96	2.55	0.98	0.79	0.39	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1.02	12.69	1.78	4.32	1.27	0.51	0.51	0.25	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	0.56	13.53	3.38	2.82	0.00	1.13	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1.29	13.43	1.81	3.61	0.00	0.77	0.26	0.52	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	0.76	9.11	1.14	1.90	0.00	0.38	0.76	0.00	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	2.04	16.06	4.38	2.92	1.46	1.17	0.88	1.75	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	3.02	19.39	5.39	5.39	1.72	1.94	1.29	1.29	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	2.09	19.60	4.59	5.00	1.67	1.67	0.42	0.42	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	4.97	13.50	4.50	2.13	1.89	0.71	0.47	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	4.98	20.09	4.34	5.46	0.64	0.64	1.29	0.48	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	5.39	17.51	5.39	0.67	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1.41	16.43	2.35	4.69	1.41	0.63	0.63	0.47	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.00	10.32	0.98	3.93	1.47	0.49	0.49	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.00	4.36	0.87	6.11	0.00	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1.91	18.52	3.82	5.73	0.76	0.95	0.57	0.19	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	2.18	17.01	3.92	10.03	0.00	0.44	1.31	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	0.50	12.49	10.99	8.50	0.00	1.00	0.00	2.00	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	0.94	19.03	3.96	9.23	0.75	1.13	1.51	0.19	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	0.91	19.55	3.64	12.28	0.45	0.00	1.36	1.82	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1.25	20.36	3.13	8.77	0.31	0.63	1.25	1.88	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	1.47	28.25	2.78	12.25	0.49	0.65	1.31	0.82	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	0.87	20.32	3.48	9.29	1.16	0.29	0.87	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	0.90	28.10	4.48	12.85	0.00	0.90	0.90	0.60	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	0.92	11.82	3.69	3.14	1.48	1.11	0.55	0.74	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	0.57	12.55	3.42	3.71	1.14	0.00	1.43	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	0.41	11.84	4.08	5.31	0.82	1.22	0.00	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	4.93	14.44	6.34	3.52	1.06	0.70	0.35	0.70	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	3.17	11.40	4.12	3.17	1.90	1.58	0.32	0.32	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	2.12	13.01	4.24	5.14	1.21	0.30	0.91	1.21	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	7.24	17.07	4.14	6.72	1.03	0.52	1.03	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	2.66	17.93	1.33	1.33	1.33	0.00	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	3.33	10.77	2.05	2.31	1.28	1.80	1.03	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	4.35	18.66	3.58	4.35	1.53	0.51	0.51	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	0.76	22.72	5.30	3.79	0.00	0.76	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	4.37	26.21	4.70	6.05	1.34	2.02	1.01	2.69	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1.45	16.42	3.38	3.62	0.72	0.48	0.48	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	0.45	9.36	0.89	3.12	2.23	0.45	0.00	0.89	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	0.49	12.20	5.37	4.39	0.98	0.00	0.98	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	1.53	14.67	3.67	1.83	0.61	0.31	0.61	0.31	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	6.51	6.51	16.27	0.00	0.00	3.25	6.51	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	1.32	7.61	2.98	4.30	0.66	0.33	0.33	0.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	3.83	18.06	6.02	6.57	1.09	1.64	0.55	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	1.81	19.18	4.34	5.43	0.72	0.36	0.36	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	0.71	11.03	2.85	5.34	1.07	1.07	0.71	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	2.39	20.29	2.39	3.58	0.00	2.39	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	3.52	21.80	3.79	2.03	0.95	1.35	1.35	0.81	3.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	4.04	14.01	4.04	2.96	0.54	0.54	0.27	0.00	0.54
immature langerhans cells, donor1	11904-125F5	4.84	15.98	6.54	2.66	0.48	1.45	0.48	0.24	0.00
immature langerhans cells, donor2	11905-125F6	16.63	26.93	11.09	5.54	3.17	0.79	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	2.37	6.06	1.80	0.66	0.00	0.47	0.38	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	19.51	15.93	11.06	1.63	4.88	1.95	0.65	0.33	0.00
kidney, adult, pool1	10017-101C8	41.05	41.05	10.91	12.12	3.90	1.70	2.40	0.40	0.60
kidney, fetal, pool1	10045-101F9	53.83	73.28	21.72	5.02	4.88	3.61	3.54	0.21	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	9.94	25.00	9.66	7.10	0.71	1.28	0.43	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	70.50	18.66	17.56	16.31	2.21	1.52	1.52	0.55	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	28.08	29.36	17.43	6.06	4.40	3.30	1.10	0.00	0.00
left atrium, adult, donor1	10079-102A7	16.35	25.06	14.17	3.27	0.54	0.54	0.54	0.54	1.09
left ventricle, adult, donor1	10078-102A6	42.98	14.16	6.57	3.54	1.52	0.51	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	3.56	23.26	4.10	1.37	0.55	1.37	0.82	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	16.17	14.37	6.83	6.83	1.80	0.36	1.08	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	27.72	25.00	7.07	9.78	1.09	0.00	1.09	0.54	0.54
leiomyoma cell line:15425	10571-108B4	14.57	18.45	7.77	6.07	1.70	1.70	0.73	0.73	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	95.24	19.05	12.70	19.05	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	20.91	17.77	8.36	1.05	0.00	0.00	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	6.97	31.29	10.74	2.95	1.18	1.65	0.94	0.24	0.12
liposarcoma cell line:KMLS-1	10782-110G8	12.03	17.50	7.34	2.97	0.47	1.09	0.94	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	48.49	45.81	38.99	5.73	7.43	5.97	2.19	0.85	0.12
liver, adult, pool1	10018-101C9	153.96	49.59	12.80	23.17	1.62	2.11	1.46	4.86	8.59
liver, fetal, pool1	10086-102B5	46.09	44.21	11.29	2.82	2.82	1.88	5.64	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	4.52	5.54	1.90	1.46	0.00	0.29	0.73	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	2.95	7.01	2.03	0.92	0.00	0.18	0.37	0.18	0.00
locus coeruleus, adult, donor10258	10375-105G6	1.97	5.36	2.26	4.80	0.00	0.28	0.28	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	4.63	5.05	0.42	1.26	0.00	0.00	0.00	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	75.01	36.54	16.61	9.27	4.43	2.08	1.80	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	18.61	13.10	11.03	2.76	2.76	3.45	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	77.51	68.81	48.11	15.55	3.82	7.12	2.50	0.13	0.13
lung, adult, pool1	10019-101D1	59.54	44.89	17.96	8.51	1.89	2.72	3.07	1.54	1.77
lung, fetal, donor1	10068-101I5	164.97	58.22	31.39	16.27	4.00	0.86	2.85	0.86	2.28
lung, right lower lobe, adult, donor1	10075-102A3	73.77	31.62	21.54	19.70	1.83	2.29	0.92	0.46	0.46
lymph node, adult, donor1	10077-102A5	24.61	64.38	12.31	8.05	2.84	3.31	2.37	0.95	0.95
lymphangiectasia cell line:DS-1	10727-110A7	27.18	86.58	8.33	10.30	5.70	9.21	5.92	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	25.20	46.79	21.43	9.51	2.41	4.38	1.21	0.30	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	29.73	16.99	20.39	8.49	3.40	0.85	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	17.32	25.75	8.88	4.00	0.89	0.00	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	40.68	29.68	11.62	3.32	1.45	1.87	1.45	0.21	0.21
mature adipocyte, donor3	12233-129G1	52.63	18.73	11.62	7.59	0.95	0.47	1.66	0.47	0.00
mature adipocyte, donor4	12234-129G2	32.38	18.16	13.42	6.32	0.26	0.53	1.32	0.00	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	11.20	94.11	7.39	12.63	5.24	2.14	4.53	0.48	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	2.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	1.66	8.28	1.66	0.18	0.00	0.37	0.18	0.00	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	0.00	1.59	1.27	0.32	0.00	0.32	0.32	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	0.00	0.43	1.28	2.56	0.00	0.43	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	3.21	4.05	0.68	0.17	0.17	0.34	0.34	0.17	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	1.70	6.15	1.27	0.64	0.21	0.00	0.42	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	5.78	1.93	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	14.35	28.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	3.95	3.95	1.44	0.72	0.00	0.00	0.72	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	8.44	11.68	3.89	0.65	0.00	1.30	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	8.82	14.55	2.01	2.01	0.46	0.46	0.62	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	8.00	10.86	4.00	1.55	0.65	0.49	0.57	0.00	0.00
medulla oblongata, newborn, donor10223	10361-105F1	3.12	3.47	1.74	2.43	0.69	0.35	0.69	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	16.16	17.27	12.40	1.77	0.22	0.22	0.22	0.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	25.43	41.45	24.09	5.38	3.67	3.55	0.98	0.24	0.00
melanoma cell line:COLO 679	10514-107E1	4.46	7.19	3.74	1.72	0.57	1.15	0.00	0.57	0.43
melanoma cell line:G-361	10465-106H6	13.03	8.69	13.57	6.24	1.36	3.26	0.00	2.44	1.90
meningioma cell line:HKBMM	10691-109F7	40.70	25.33	23.16	27.32	1.09	1.99	0.90	0.72	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	14.10	2.64	2.64	1.76	0.00	2.64	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	4.93	32.92	3.89	3.63	2.85	0.78	1.56	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	69.66	9.05	22.71	24.55	0.46	0.77	0.15	1.23	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	51.63	9.45	15.45	12.54	0.91	0.00	0.36	0.36	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	29.40	6.63	11.18	7.04	0.00	0.83	0.83	1.24	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	18.68	11.94	8.57	3.09	0.98	0.70	1.12	0.42	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.60	12.13	10.98	5.97	1.16	0.58	0.96	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	22.21	18.05	11.80	6.94	0.69	0.00	0.69	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	49.26	10.47	14.07	12.87	0.34	0.51	0.86	0.69	1.54
mesenchymal precursor cell - cardiac, donor2	11753-123G7	30.36	8.63	10.93	6.21	0.69	0.35	0.46	0.46	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	82.23	13.00	19.50	22.55	0.66	0.53	0.66	0.66	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	102.90	15.80	15.80	10.40	0.95	0.95	1.62	1.89	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	35.28	18.92	12.38	10.10	1.14	0.85	0.71	0.85	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	31.62	21.41	16.47	6.59	0.99	0.99	1.32	0.66	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	52.58	21.45	14.25	9.69	1.25	0.69	0.97	0.69	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	46.78	16.41	19.20	19.90	1.40	0.35	0.70	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	25.32	14.29	12.66	10.62	1.02	0.61	0.61	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	29.83	15.82	10.78	6.11	1.08	2.16	1.08	0.36	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	67.66	18.72	16.55	17.48	0.93	0.83	0.93	1.14	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	105.79	23.48	15.96	11.40	1.60	1.60	1.37	0.46	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	41.54	21.40	12.59	10.91	0.84	0.42	1.26	1.68	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.82	17.93	10.16	10.01	1.64	0.90	0.90	0.45	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	35.01	14.53	15.23	10.33	1.14	1.14	0.70	0.61	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	19.51	16.20	11.78	5.15	1.10	3.31	0.74	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	37.49	20.03	12.88	5.15	0.00	1.14	1.14	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	29.47	19.37	7.16	9.26	0.84	1.68	0.42	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	87.68	9.59	12.79	18.72	0.00	0.46	1.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	91.57	13.30	14.32	28.39	1.28	0.26	0.77	0.51	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	102.87	16.49	14.92	26.70	0.52	0.26	1.05	1.57	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	105.98	17.25	14.17	31.12	0.92	0.00	0.62	3.08	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	82.37	11.53	15.53	32.48	0.71	0.47	1.18	1.41	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	91.72	11.85	22.68	22.00	0.34	0.34	2.03	1.02	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	90.38	15.33	14.15	35.37	0.39	0.79	0.79	1.57	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	86.19	9.73	15.29	29.66	1.39	0.46	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	113.06	14.42	20.19	26.25	1.15	0.87	1.73	2.02	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	107.76	14.50	17.62	18.52	0.67	0.45	0.89	1.56	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	100.47	12.74	14.90	23.55	0.96	0.96	1.92	1.68	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	118.07	19.07	20.53	6.60	0.73	0.73	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	85.26	13.76	17.79	20.14	0.34	0.67	1.01	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	95.39	12.69	23.33	29.88	0.41	0.41	0.41	2.05	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	95.79	15.03	16.75	27.92	0.00	0.00	0.43	1.29	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	112.11	8.20	21.88	38.28	0.00	5.47	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	82.64	25.82	10.33	25.82	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	80.55	10.39	16.24	22.41	0.65	0.32	1.62	1.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	98.94	10.18	17.46	33.46	2.91	0.00	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	103.95	19.19	22.92	35.72	0.53	0.00	1.07	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	87.50	7.36	18.81	28.62	0.82	0.00	1.64	1.64	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	102.23	13.61	17.49	24.10	1.55	0.78	1.55	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	90.25	16.79	27.28	33.58	0.00	0.00	2.10	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	77.49	14.90	9.93	38.75	1.99	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	76.28	0.00	14.30	23.84	0.00	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	89.54	8.89	16.01	26.68	2.37	1.19	0.00	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	107.22	13.40	29.24	36.55	0.00	1.22	1.22	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	84.87	11.40	16.47	28.50	3.80	2.53	1.27	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	73.12	10.69	18.28	24.49	0.00	0.34	0.69	1.03	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	51.58	12.90	19.34	38.69	0.00	0.00	4.30	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	79.84	3.99	27.94	51.89	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	65.43	13.78	10.33	58.55	0.00	3.44	3.44	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	75.79	8.15	15.48	39.52	0.00	0.41	0.81	1.63	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	92.16	12.71	21.45	38.93	0.00	0.79	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	38.91	8.84	12.38	25.94	1.18	0.00	0.59	1.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	31.17	14.03	15.27	14.34	0.00	0.31	0.31	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	52.13	10.69	20.05	20.05	0.00	0.00	0.00	2.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	7.10	5.91	9.46	7.10	0.00	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	10.27	12.84	5.14	0.00	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	14.46	8.95	7.57	4.82	0.69	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	7.92	12.86	7.92	8.91	0.00	0.49	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	10.09	5.61	4.49	1.12	0.00	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.90	9.54	5.72	8.27	0.00	0.64	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	15.31	8.46	2.82	11.28	0.81	0.40	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	2.18	6.54	8.72	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	10.14	6.34	15.20	1.27	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	15.78	6.07	6.07	7.28	0.00	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	9.04	4.52	18.08	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	17.30	4.94	4.94	10.71	0.82	1.65	0.82	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	27.98	8.73	9.33	7.54	0.79	0.40	0.20	0.60	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	23.04	9.09	10.71	14.60	0.65	0.00	0.00	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	21.39	10.19	17.32	13.24	2.04	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	32.50	26.31	23.99	3.87	0.00	1.55	2.32	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	35.67	85.76	29.06	22.44	11.34	7.56	1.18	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	60.00	16.91	21.55	4.63	2.09	1.39	0.46	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	0.00	21.37	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.96	8.63	7.60	1.95	1.34	0.31	0.21	0.72	0.21
mesothelioma cell line:Mero-25	10850-111F4	13.39	10.67	7.49	4.31	0.91	0.91	0.45	1.36	0.00
mesothelioma cell line:Mero-41	10851-111F5	58.67	17.36	29.58	13.45	1.22	1.96	0.24	0.98	0.49
mesothelioma cell line:Mero-48a	10852-111F6	97.21	49.82	29.67	16.83	5.98	5.98	1.33	1.33	0.44
mesothelioma cell line:Mero-82	10853-111F7	33.64	8.15	9.46	19.45	1.31	0.26	0.53	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	18.21	22.47	13.96	3.23	2.55	1.36	0.34	0.51	0.85
mesothelioma cell line:Mero-84	10855-111F9	27.30	13.90	8.85	4.55	1.77	0.51	0.51	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	70.39	14.08	13.04	13.87	1.86	1.24	0.83	1.04	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	41.08	16.90	9.94	5.80	1.16	1.82	0.66	0.50	0.00
mesothelioma cell line:NCI-H226	10846-111E9	16.83	3.44	7.42	1.63	0.36	0.36	0.18	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	20.33	8.03	9.74	11.10	1.20	0.68	0.17	0.68	0.34
mesothelioma cell line:NCI-H28	10845-111E8	19.59	19.34	8.14	5.85	2.80	0.51	0.76	0.00	0.00
mesothelioma cell line:No36	10857-111G2	12.40	10.44	8.16	3.91	1.30	0.65	0.98	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	14.90	13.01	6.23	2.71	0.27	0.54	0.27	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	0.77	13.05	2.88	1.34	0.77	1.15	0.00	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	2.08	21.25	3.18	3.30	1.47	1.47	0.24	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	0.36	15.08	1.44	0.36	0.90	1.08	0.90	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	37.22	40.81	17.96	27.42	6.86	3.59	0.98	3.26	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.50	42.60	23.52	6.57	2.33	2.97	0.00	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	16.82	55.75	8.29	6.22	4.38	3.23	2.53	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	25.12	34.82	11.04	4.95	1.52	5.33	1.33	0.95	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	2.22	39.36	5.91	6.84	2.40	2.59	0.37	0.55	0.18
myeloma cell line:PCM6	10474-106I6	26.49	34.79	7.71	13.05	2.57	3.76	1.98	0.20	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	17.76	19.78	9.13	1.52	2.03	2.54	2.03	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	30.01	13.73	13.53	8.43	1.57	0.59	0.98	0.59	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	26.63	29.30	10.47	8.80	4.68	2.45	0.45	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	17.13	25.59	10.96	8.16	3.82	1.32	0.74	0.22	0.22
nasal epithelial cells, donor2	12227-129F4	48.02	20.42	27.60	6.62	2.76	1.10	1.10	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	0.23	4.14	1.15	0.46	0.46	0.00	0.23	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	4.86	7.11	2.62	3.55	0.56	0.56	0.19	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	1.69	14.13	1.90	1.90	0.84	0.21	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	0.37	4.47	2.05	0.75	0.19	0.37	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.24	8.54	1.19	0.95	0.47	0.00	0.47	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	9.82	17.90	6.49	5.38	0.16	0.63	0.63	0.00	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	5.23	12.68	7.04	3.42	0.00	1.21	0.81	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	1.27	20.98	1.27	1.27	0.00	0.00	1.91	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	118.18	19.16	17.57	21.56	0.53	0.27	0.53	0.80	0.00
neutrophil PMN, donor1	12133-128D9	0.00	267.75	29.75	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	26.56	13.28	0.00	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	56.82	0.00	18.94	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	2.20	13.19	8.96	1.01	0.34	1.35	1.01	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.80	2.40	0.80	0.80	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	50.34	8.66	17.95	13.14	0.96	0.64	0.96	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	21.81	16.03	10.25	6.31	1.31	1.84	0.26	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	5.62	6.19	2.06	0.94	0.19	0.19	0.75	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	6.18	2.06	2.06	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	3.76	8.86	2.15	0.27	0.27	0.00	0.27	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	3.64	5.82	1.09	1.09	0.00	0.00	0.73	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	2.89	2.62	1.31	0.52	0.00	0.00	0.52	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	1.72	9.87	0.00	0.00	0.00	0.43	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	1.66	3.86	0.63	0.39	0.00	0.16	0.32	0.00	0.00
olfactory region, adult	10195-103E6	1.15	4.20	0.57	0.96	0.00	0.00	0.57	0.00	0.00
optic nerve, donor1	10277-104E7	4.00	8.00	2.00	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	25.17	51.37	14.35	15.61	6.61	5.24	1.82	0.34	1.71
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	4.95	24.32	6.73	7.14	1.65	0.96	0.96	0.27	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	57.57	35.05	25.23	7.79	7.79	4.23	1.86	0.85	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	36.62	15.48	23.56	9.47	2.66	3.81	0.46	0.58	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	118.47	27.34	34.39	8.82	2.94	2.35	0.88	1.18	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	15.88	22.42	10.28	0.93	0.93	2.80	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	17.18	7.42	5.73	2.33	0.21	0.85	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	108.84	37.91	19.57	9.61	1.22	0.96	2.88	1.05	3.67
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	45.83	45.10	17.78	8.07	2.20	4.77	6.97	0.55	0.00
pancreas, adult, donor1	10049-101G4	11.29	30.10	8.47	8.47	0.94	2.82	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	230.34	25.44	79.95	52.55	14.54	10.90	0.00	2.80	2.24
papillary adenocarcinoma cell line:8505C	10437-106E5	51.62	12.10	23.34	13.12	1.87	1.70	0.34	1.02	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	61.76	102.50	38.75	28.31	6.13	9.27	2.65	1.16	1.16
paracentral gyrus, adult, pool1	10035-101E8	1.83	4.85	1.83	0.46	0.18	0.09	0.09	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	1.47	0.73	2.20	0.73	0.00	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	3.76	2.82	1.88	1.88	0.00	1.88	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	1.71	5.42	0.57	1.14	0.29	0.29	0.00	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	3.88	5.02	1.32	0.53	0.18	0.18	0.44	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	0.97	10.67	1.94	0.00	0.97	0.97	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	1.87	4.11	0.37	1.50	1.12	0.00	0.37	0.37	0.00
parotid gland, adult	10199-103F1	97.43	38.23	12.33	33.92	4.32	1.23	1.23	0.00	0.00
penis, adult	10200-103F2	26.32	17.19	13.96	15.04	1.07	0.54	1.07	1.07	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	1.30	8.18	0.37	0.74	0.00	0.00	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	126.17	34.24	43.56	13.11	5.25	3.64	1.02	0.87	0.29
pineal gland - adult, donor10196	10179-103C8	4.52	5.81	2.58	1.29	1.29	0.65	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	4.74	11.25	2.37	0.59	0.00	0.59	0.59	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	3.76	3.76	0.63	1.88	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	20.24	19.22	7.08	6.07	2.02	2.02	1.01	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	22.41	43.26	3.13	4.69	1.56	1.56	2.08	0.00	1.04
pituitary gland, adult, donor10258	10378-105G9	3.40	20.43	1.70	11.92	0.85	0.00	1.70	0.00	0.85
placenta, adult, pool1	10021-101D3	109.12	48.70	44.72	30.53	15.27	10.21	1.08	1.40	0.97
plasma cell leukemia cell line:ARH-77	10840-111E3	5.30	28.74	6.36	2.52	1.59	2.52	1.59	0.26	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	98.83	47.16	30.82	8.56	3.58	2.49	1.56	0.93	1.09
pons, adult, pool1	10033-101E6	3.01	6.54	1.72	0.60	0.26	0.26	0.26	0.09	0.00
postcentral gyrus, adult, pool1	10032-101E5	1.22	3.75	1.83	0.26	0.09	0.17	0.61	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	8.37	58.56	6.27	0.00	6.27	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	11.02	5.51	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	11.74	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	42.53	19.08	11.07	9.91	1.02	3.06	1.02	1.02	0.44
prostate cancer cell line:PC-3	10439-106E7	12.89	12.52	4.90	5.08	0.73	1.45	0.73	0.00	0.00
prostate, adult, pool1	10022-101D4	36.46	22.13	10.52	5.80	1.27	0.91	0.91	0.09	0.63
putamen, adult, donor10196	10176-103C5	4.25	6.37	1.18	0.94	0.00	0.00	0.47	0.00	0.00
putamen, adult, donor10252	10152-102I8	3.92	1.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	1.09	1.09	0.00	1.09	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	0.48	2.90	0.72	0.48	0.48	0.00	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	1.50	3.75	3.00	3.75	0.00	0.00	1.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	36.66	50.62	31.71	3.49	5.53	4.65	1.16	0.58	0.58
rectum, fetal, donor1	10067-101I4	15.30	52.86	15.30	23.65	0.00	0.00	2.78	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	55.33	30.53	22.05	14.42	0.64	2.12	0.42	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	3.31	20.71	4.97	7.46	0.00	0.00	0.41	0.00	0.41
retina, adult, pool1	10030-101E3	61.73	44.53	14.51	6.56	2.68	1.79	2.58	0.60	0.20
retinoblastoma cell line:Y79	10475-106I7	0.26	4.16	0.26	1.30	0.00	0.00	0.00	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.25	12.42	1.11	0.49	0.74	0.12	1.48	0.12	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	1.97	16.59	3.09	1.12	0.56	0.56	0.84	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	68.96	15.16	18.95	3.03	0.76	0.76	3.03	0.00	0.00
salivary acinar cells, donor1	11771-123I7	62.48	8.90	16.83	15.38	0.97	0.00	0.32	0.65	0.65
salivary acinar cells, donor2	11772-123I8	41.58	9.50	17.21	3.44	1.10	0.69	0.83	1.51	1.65
salivary acinar cells, donor3	11773-123I9	34.43	14.57	15.23	3.97	2.65	0.66	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	37.18	37.18	10.87	12.01	5.72	1.14	3.43	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	10.62	28.58	10.20	3.71	2.61	2.36	0.51	0.25	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	8.46	30.92	9.17	3.53	1.41	3.41	1.29	0.47	0.47
seminal vesicle, adult	10201-103F3	84.65	32.27	21.16	19.58	1.59	1.59	1.06	4.76	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	73.12	20.16	25.26	15.06	2.19	3.16	1.46	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	14.09	18.12	12.83	0.50	0.75	3.02	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	14.05	25.09	12.04	4.01	1.00	1.00	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	164.01	93.08	28.74	69.85	8.87	3.63	11.95	2.82	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	18.57	30.62	13.37	2.87	1.33	0.77	0.33	0.00	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	25.81	21.55	16.52	11.74	1.94	2.58	1.55	0.52	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	7.80	13.48	7.09	0.00	0.71	0.00	0.71	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	12.95	15.11	8.28	4.32	0.48	0.36	1.08	0.36	0.48
skeletal muscle, fetal, donor1	10066-101I3	9.05	20.10	16.08	11.06	2.01	0.00	3.02	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	33.93	33.93	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	35.98	32.19	16.41	8.21	1.89	0.63	0.63	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	8.67	30.35	5.00	1.67	0.00	1.67	1.67	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1.58	10.09	0.95	1.26	0.63	0.32	0.63	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.39	11.37	0.19	1.73	0.77	0.77	1.73	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	30.00	16.98	24.56	8.41	1.32	1.48	0.49	0.49	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1.45	9.33	1.77	0.32	0.00	0.16	0.80	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	1.09	13.73	1.31	1.96	0.22	0.44	0.65	0.00	0.22
small intestine, adult, pool1	10024-101D6	15.77	46.46	6.93	8.12	1.07	2.39	0.84	0.60	1.43
small intestine, fetal, donor1	10064-101I1	46.68	83.78	18.18	19.41	4.67	1.97	7.13	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	0.00	3.08	0.00	0.00	0.51	0.00	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	16.80	16.54	6.72	1.81	0.26	0.26	1.29	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	0.80	31.36	2.41	1.88	1.34	0.80	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	5.05	11.47	1.84	0.69	0.69	0.69	0.69	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	5.13	17.35	1.18	0.79	1.58	0.00	2.37	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	2.08	6.23	2.08	2.77	0.00	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	21.95	14.64	9.76	7.93	0.00	1.22	1.22	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	2.30	4.59	1.38	4.59	0.46	0.46	0.00	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	258.23	25.54	34.20	12.84	2.09	1.79	1.49	0.75	0.30
spleen, adult, pool1	10025-101D7	21.70	74.67	11.01	9.25	2.86	2.75	2.42	0.66	1.98
spleen, fetal, pool1	10044-101F8	20.50	65.87	14.38	3.42	2.78	2.78	4.05	0.16	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	3.52	19.46	3.00	6.21	0.93	1.45	0.93	0.10	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	29.43	40.06	30.38	6.65	3.04	3.42	1.33	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	63.25	73.73	32.50	32.85	30.75	8.04	0.70	3.49	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	9.38	26.19	12.90	3.13	2.74	3.91	0.39	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	29.49	52.90	24.31	7.43	3.60	4.39	1.35	0.23	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	27.96	20.33	8.47	13.56	1.69	0.00	0.85	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	11.85	22.00	15.23	0.85	2.54	1.27	1.27	0.00	0.00
stomach, fetal, donor1	10062-101H8	66.21	51.26	35.24	5.34	1.07	5.34	8.54	0.00	0.00
submaxillary gland, adult	10202-103F4	48.42	34.18	16.52	8.55	3.42	2.85	0.57	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	5.19	13.29	2.49	2.08	0.21	0.62	0.21	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	2.07	1.55	0.52	0.52	0.00	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	6.36	4.95	1.41	3.53	0.71	0.71	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	1.60	30.95	3.90	2.29	1.83	1.60	1.83	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	2.37	5.09	2.46	0.93	0.08	0.25	0.34	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	0.00	3.56	1.42	0.71	0.00	0.71	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	2.20	5.71	1.32	1.76	0.44	0.00	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	167.92	21.99	24.79	19.55	1.40	1.05	0.35	2.44	0.00
tenocyte, donor2	11765-123I1	74.01	14.12	19.46	14.88	1.53	0.38	1.14	0.38	0.00
tenocyte, donor3	11768-123I4	68.94	16.31	8.15	18.53	0.00	0.37	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	3.57	9.18	8.33	3.40	1.36	1.87	0.68	0.00	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	4.78	24.20	6.78	4.32	0.92	2.31	0.62	0.15	0.00
teratocarcinoma cell line:PA-1	10807-111A6	1.08	11.78	3.10	2.32	1.24	1.39	0.46	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.71	8.38	19.68	10.92	2.41	2.29	0.13	0.63	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1.89	4.92	2.65	0.76	0.38	0.00	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	4.04	1.64	6.54	0.87	0.55	0.22	0.00	0.11	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	8.79	13.03	9.45	6.84	1.30	0.98	0.00	0.00	0.65
testis, adult, pool1	10026-101D8	84.93	49.39	26.41	16.43	3.54	3.54	3.97	4.72	7.19
testis, adult, pool2	10096-102C6	106.46	47.82	32.93	13.98	0.90	2.26	2.71	0.90	0.45
thalamus - adult, donor10196	10168-103B6	2.21	4.42	3.31	1.10	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	3.44	8.44	1.56	2.34	0.16	0.31	0.47	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	9.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	1.98	3.79	1.48	3.46	0.33	0.16	0.66	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	1.15	1.73	0.58	0.00	0.00	0.00	1.15	0.00	0.00
throat, adult	10209-103G2	51.43	17.48	9.49	12.23	1.75	0.75	1.00	0.75	0.75
throat, fetal, donor1	10061-101H7	54.85	43.57	28.64	19.81	1.52	2.44	4.57	0.91	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	2.38	13.91	5.37	3.18	0.40	0.00	1.19	0.00	0.00
thymus, adult, pool1	10027-101D9	8.75	54.58	6.96	2.68	2.19	2.49	2.19	0.70	0.89
thymus, fetal, pool1	10043-101F7	24.21	63.90	9.97	3.01	2.49	1.77	3.12	0.62	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	11.17	17.95	7.71	3.32	0.80	1.46	0.13	0.40	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	62.02	27.80	25.98	25.42	1.96	2.10	0.84	0.70	0.70
thyroid, adult, pool1	10028-101E1	86.97	30.79	16.61	10.82	1.77	1.87	1.49	0.65	1.21
thyroid, fetal, donor1	10060-101H6	155.03	47.46	26.10	20.30	1.58	1.58	3.16	1.32	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	58.51	27.72	6.16	3.08	3.08	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	23.72	12.56	7.44	8.14	0.70	1.40	0.47	0.23	0.00
tongue, fetal, donor1	10059-101H5	36.65	27.19	16.55	27.98	1.18	1.18	1.97	1.18	0.79
tonsil, adult, pool1	10047-101G2	66.72	63.31	16.13	5.91	4.21	3.81	2.30	0.40	0.60
trachea, adult, pool1	10029-101E2	97.26	26.34	13.58	10.63	1.64	1.39	1.31	0.57	1.23
trachea, fetal, donor1	10058-101H4	121.18	30.78	26.16	32.31	0.77	0.77	1.92	0.77	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	46.06	15.59	15.23	17.01	0.71	1.06	0.71	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	65.35	29.08	19.45	10.23	2.94	2.43	1.11	0.30	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	13.01	15.83	9.40	7.52	1.72	0.78	0.78	0.63	1.41
tridermal teratoma cell line:HGRT	10694-109G1	64.69	22.83	5.71	1.90	0.00	1.90	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	6.77	14.05	7.36	1.02	0.68	1.35	0.42	0.17	0.25
umbilical cord, fetal, donor1	10057-101H3	54.25	39.64	12.52	12.52	2.09	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	34.81	26.11	14.84	4.27	0.51	0.68	0.85	0.00	0.17
uterus, fetal, donor1	10055-101H1	35.83	32.25	19.97	15.87	0.00	2.56	2.56	0.00	0.00
vagina, adult	10204-103F6	21.32	16.80	7.75	1.29	0.00	0.00	1.94	0.00	0.00
vein, adult	10191-103E2	25.87	43.62	13.15	15.34	1.75	2.41	2.63	0.22	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	5.07	40.59	7.21	12.82	3.20	2.14	2.14	0.27	0.27